Inhibitory Activity of Chemical Constituents from Vitellaria paradoxa Gaertn. (Sapotaceae) Against Pathogens Associated with Respiratory Tract Infections

Inhibitory Activity of Chemical Constituents from Vitellaria paradoxa Gaertn. (Sapotaceae) Against Pathogens Associated with Respiratory Tract Infections | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Inhibitory Activity of Chemical Constituents from Vitellaria paradoxa Gaertn. (Sapotaceae) Against Pathogens Associated with Respiratory Tract Infections Olusesan Ojo, Edwin M. Mmutlane, Derek T. Ndinteh This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3967817/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Vitellaria paradoxa Gaertn. is a commonly used medicinal plant for the treatment of tuberculosis (TB) and other respiratory infections in Africa. Therefore, its phytochemicals can be explored in rational drug discovery, development, and design against respiratory-tract infections. The aim of this study is to identify chemical composition of V. paradoxa hexane stem-bark extract, and further isolate possible antimicrobial agents from its crude extract. 48 phytochemicals, including1-heptacosanol, 2-nonenal, (E)-, and hexadecanoic acid, methyl ester were identified using GC-MS. Column chromatography led to the isolation of three compounds, including 11-hydroxy β-amyrin cinnamate ( 1 ), α-amyrin cinnamate ( 2 ), and sitosterol cinnamate ( 3 ). All the compounds showed activity against all the tested pathogens, with compound ( 3 ) showed better activity against all bacterial strains, with minimum inhibitory concentrations (MICs) varying from 0.0625 to 0.25 mg/ml. Compounds ( 1 ) and ( 2 ) showed no cytotoxicity against the cervical cancer cell line (HeLa) (IC 50 ; 82.53 ± 4.07 and 77.82 ± 10.5 respectively). To our knowledge, compounds 2 and 3 are reported here from the stem-bark part of the plant for the first time. Similarly, inhibitory activities of compounds 1 – 3 against the tested strains are studied here for the first time. These results provide in part scientific justification for the traditional uses of V. paradoxa for treating respiratory tract infections, including tuberculosis in Africa. Medicinal Chemistry Vitellaria paradoxa Sapotaceae Respiratory tract infections Tuberculosis Cytotoxicity Sitosterol cinnamate Figures Figure 1 Figure 2 Figure 3 1 Introduction Respiratory tract infections (RTIs), such as pneumonia impose immense health burden in the world, accounting for over four millions fatalities yearly (Forum of International Respiratory Societies and European Respiratory Society, 2017 ). It is particularly a leading cause of death among children within the age of 5 years than older children or adults in developing countries. It is estimated that over 2 million children within this age group die due to pneumonia in developing nations, and over 43% of global death rates from acute RTIs are linked to developing countries, including Nigeria, Ethiopia, Democratic Republic Congo (Demissie et al., 2021 ). These figures do not include the over 1.2 million deaths recorded as due to tuberculosis (TB), which is another fatal respiratory-cum-lung infection (WHO, 2020). Together, respiratory tract infections and tuberculosis are two significant contributors to the incessant rising in the global burden of communicable diseases (Michaud, 2009 ). Despite significant breakthroughs in the rollout of antibiotics to curb the menace of these infections over the past decades, there are still the problem of antimicrobial resistance in addition to the adverse effects of these antibiotics on the host-like hypersensitivity. Drug-resistant bacterial infections are on the increase worldwide, and this has called for continued surveillance and desperate search for new drug pipelines against menace of tuberculosis and other bacterial pathogens associated with respiratory infections, including methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa , Enterococcus faecalis , Klebsiella oxytoca , Escherichia coli , Klebsiella aerogenes , and Enterobacter cloacae (Mirzayev et al., 2021 ; Prat and Lacoma, 2016 ; Yoo et al., 2020 ; Husain et al., 2021 ; Passarelli-Araujo et al., 2019 ; Lee et al., 2019 ; Zhong et al., 2018 ). Natural products have historically been acting as an invaluable source of therapeutical agents in many disease areas, very much in the area of infections due to pathogenic bacteria (Atanasov et al., 2021 ). In fact, they have been at the origin of many clinically used drugs, such as streptomycin and rifamycin against tuberculosis and other related infections (Dong et al., 2017 ). Natural plant-based drugs could serve as anti-infective agents with novel modes of actions (Porras et al., 2021 ). Many plant species in the family Sapotaceae have been reported to possess several pharmacological activities, including antimycobacterial (da Costa et al., 2013 ; Kumatia and Appiah-Opong, 2021 ; McGaw et al., 2015 ). The species Vitellaria paradoxa Gaertn. (Fig. 1 ) is a widely distributed medicinal plant in sub-Sahara Africa that has been traditionally used in the treatment of respiratory tract infections and related symptoms, including tuberculosis (Ogbole and Ajaiyeoba, 2009 ), bronchitis, coughs and whooping cough (Ariyo et al., 2020 ; Lawal et al., 2020 ), and lung disorders (Nadembega et al., 2011 ). It has been reported to possess antioxidant, anti-inflammatory, anticancer (Ojo et al., 2021 ), antidiarrhoeal, and insecticidal activities (Buxton et al., 2020 ). Prior phytochemical investigation led to the identification of Androseptoside A, Lupeol acetate (Akihisa et al. 2010 ), gallic acid, ferulic acid, and rutin (Ojo et al., 2021 ). However, little is known about its anti-infective potential against causative agents of respiratory infections. The present study, thus, described GC-MS metabolites profiling of V. paradoxa , and the chromatographic isolation of cinnamoyl compounds from the hexane extract. The study also described the pharmacological activities of the isolated compounds against Mycobacterium smegmatis which is used as “surrogate” model for the virulent Mycobacterium tuberculosis , together with six respiratory-tract-associated bacterial pathogens, including Escherichia coli , Klebsiella aerogenes , Staphylococcus aureus , Enterobacter cloacae , Klebsiella oxytoca , and Enterococcus faecalis . 2 Materials and methods 2.1 General instrumentations Brucker Avance III NMR spectrometer was used to record the 1 H (frequency; 500 MHz), 13 C (frequency; 125 MHz) and 2D-NMR spectra of the isolated compounds using tetramethylsilane (TMS) as internal standard. Also, deuterated chloroform (d-CHCl 3 ) was employed as solvent for running the NMR analysis. Mass spectra were done and recorded on a Brucker Compact mass spectrometer (University of the Witwatersrand, South Africa). IR was performed using Perkin Elmer FTIR 600 series. Column chromatography was performed using column (3 cm × 55 cm) with silica gel (mesh size; 60–120). Thin-layer chromatography (TLC) analysis was carried out on pre-coated silica gel 60 F 254 plates (Macherey-Nagel GmbH & Co. KG) with layer thickness of 0.20 mm. The plates were treated with p -anisaldehyde-sulphuric acid reagent, and visualized under UV light (254 and 365 nm). Chemicals used in the experiment were purchased from Sigma-Aldrich, South Africa. 2.2 Plant material collection The V. paradoxa (Fig. 1 ) stem-bark sample was collected from the University of Ibadan, Oyo State, Western Nigeria (Geographical location: 7 o 23̛ 28N 3 o 54̛ 60E) during the month of September, 2019. The plant sample was identified and authenticated taxonomically by Mr. D. P. O. Esimekhuai, a Chief Plant Technologist at the Botany Department, University of Ibadan, Nigeria. The voucher specimen, UIH-22897, has been deposited in the same department. The stem-bark sample was thoroughly washed and air-dried for two weeks in an open shaded place at room temperature. The air-dried samples were milled into fine powder with the aid of an industrial grinder and kept in a sealed polythene bag until further use at room temperature. 2.3 Extraction 500 g of V. paradoxa stem-bark was extracted (5 times) with n -hexane (1 L) at room temperature for 24 hrs. The extract was concentrated after filtration using a rotary evaporator under reduced pressure at 40 o C to give a yellowish waxy substance. 2.4 GC-MS analysis The hexane crude extract was subjected to GC-MS analysis after dissolving in HPLC-grade methanol and filtering through a 0.2 µm PTFE syringe-driven filter into GC-MS vials. The GC-MS instrument Agilent Technologies (GC-7890B: MS-5977AMSB) was employed in the analysis of the extract. The injector temperature was set at 290 0 C, while column oven temperature was set at 50°C to 150°C at 3°C/min, then held isothermal for 10 min and finally raised to 300°C at 10°C/min. The sample injection was 1 𝜇L. Carrier gas was pure Helium gas (99.9%) 1 ml/min in a splitless mode. The total GC run time was 19 mins with a mass detector. The ion source temperature was set at 350°C with ionization voltage of 70 eV. The inlet temperature was 250°C, with solvent delay of 10 mins. The mass scan (m/z) was run from 40 to 1000 amu. The identification of the phytochemicals present in the crude extract was achieved by comparing their spectra with the spectra fingerprint of the known compounds in the curated database of National Institute Standard and Technology, NIST version—2011. The name, molecular formula, molecular weight, and chemical structure of the phytochemicals in the analyzed extract were identified ( Table S1 ) provided in Supplementary List. Relative quantity of the phytochemicals presents in the stem-bark extract of V. paradoxa were individually expressed as percentage (%) based on peak areas produced in the chromatogram. 2.5 Column chromatographic isolation 10 g of the crude extract was fractionated using gradient elution [starting from hexane (100%), with 10% increase in chloroform to 100% chloroform] on silica gel column (3 cm × 55 cm) to yield twelve fractions (VPH 1- VPH 10) on the basis of their thin-layer chromatography (TLC) profiles. All fractions were screened against Mycobacterium smegmatis to evaluate their in vitro antimycobacterial activity using micro-dilution technique. The most bioactive fractions VPH 6 (109.5 mg), VPH 7 (2.20 g), and VPH 10 (220.9 mg) were subjected to further fractionation. Fraction VPH 6 was re-chromatographed on silica gel column, eluting with hexane-ethyl acetate (1:9 to 0:10) as mobile phase to yield four sub-fractions VPH 6A-D. The sub-fraction VPH 6A appeared as a white solid substance was recrystallized from dichloromethane/methanol to give compound 1 (11-hydroxy β-amyrin cinnamate, 15.4 mg ) . Fraction VPH 7 was further purified on silica gel column (mobile phase: hexanes-ethyl acetate 97:3 to 10:90) to give three sub-fractions VPH 7A-C. The sub-fraction VPH 7A gave compound 2 (α-amyrin cinnamate, 26.2 mg) after recrystallization from dichloromethane/methanol. Sub-fraction VPH 7B was subjected to further purification to give additional quantity of amyrin cinnamate (9.7 mg). Fraction VPH 10 was chromatographed on silica gel column (mobile phase: hexanes-ethyl acetate 85:15 to 10:90) to give three sub-fractions VPH 10 A-C. Sub-fraction VPH 10C (22.10 mg) after recrystallization from dichloromethane/methanol gave compound 3 (sitosterol cinnamate, 9. 6 mg). The structures of the compounds 1–3 were unambiguously elucidated on the basis of their obtained physical and spectroscopic data as well as comparison with those published in the literature. Compound 1, 11-hydroxy β-amyrin cinnamate : White powder; ESI-MS: [M + H] + m/z = 573.3100; MF: C 39 H 56 O 3 ; soluble in CHCl 3 ; 1 H-NMR (500 MHz, δ ppm, CHCl 3 -d = 7.24 ): 7.64 (d, 1H, J = 15.9 Hz, H − 3' ), 7.51 (m, 2H, J = 4.2 Hz, H − 6'/8' ) and 7.50 (1H, H − 7' ), 7.35 (d, 2H, J = 4.9 Hz, H − 5'/9' ), 6.44 (d, 1H, J = 10.0 Hz, H − 2' ), 5.56 (dd, 1H, H − 12 ), 4.62 (dd, 1H, J = 9.80 and 5.3 Hz, H − 3 ), 4.10 (t, 1H, J = 3.5 Hz, H − 11 ), 0.77–1.03 (s, 8×3H); 13 C-NMR (125 MHz, δ ppm, CHCl 3 -d = 77.23 ): 38.75 (CH 2 , C − 1 ), 23.96 (CH 2 , C − 2 ), 80.85 (CH, C − 3 ), 37.09 (C, C − 4 ), 55.58 (CH, C − 5 ), 18.51 (CH 2 , C − 6 ), 32.17 (CH 2 , C − 7 ), 42.32 (C, C − 8 ), 47.92 (CH, C − 9 ), 39.89 (C, C − 10 ), 81.27 (CH, C − 11 ), 124.59 (CH, C − 12 ), 139.88 (C, C − 13 ), 42.35 (C, C − 14 ), 26.87 (CH 2 , C − 15 ), 28.37 (CH 2 , C − 16 ), 33.15 (C, C − 17 ), 59.34 (CH, C − 18 ), 41.79 ( CH 2 , C − 19 ), 31.50 (C, C − 20 ), 34.00 (CH 2 , C − 21 ), 40.31 (CH 2 , C − 22 ), 28.98 (CH 3 , C − 23 ), 15.99 (CH 3 , C − 24 ), 14.33 (CH 3 , C − 25 ), 17.14 (CH 3 , C − 26 ), 25.40 (CH 3 , C − 27 ), 28.98 (CH 3 , C − 28 ), 17.74 (CH 3 , C − 29 ), 22.93 (CH 3 , C − 30 ), 167.02 (C, C − 1' ), 144.48 (CH, C − 2' ), 119.13 (CH, C − 3' ), 134.84 (C, C − 4' ), 128.26 (CH, C − 5'/9' ), 129.07 (CH, C − 6'/8' ), 130.33 (CH, C − 7' ). These data supports those reported for 11α-hydroxy-β-amyrin by Ikuta and Morikawa ( 1992 ) and its cinnamate by Sirignano et al. ( 2021 ) in the literature. Compound 2, α-amyrin cinnamate : White solid powder; ESI-MS: [M + H] + m/z = 557.4117; MF: C 39 H 56 O 2 ; m.p = 231–235 (uncorrected); soluble in CHCl 3 ; 1 H-NMR (500 MHz, δ ppm, CHCl 3 -d = 7.24 ): 7.64 (d, 1H, J = 16.0 Hz, H − 3' ), 7.52 (m, 2H, J = 3.95 Hz, H − 6'/8' ) and 7.50 (1H, H − 7' ), 7.35 (d, 2H, J = 4.15 Hz, H − 5'/9' ), 6.42 (d, 1H, J = 16.0 Hz, H − 2' ), 5.76 (dd, 1H, H − 12 ), 4.61 (dd, 1H, J = 9.80 and 6.30 Hz, H − 3 ), 0.76–1.20 (s, 8×3H); 13 C-NMR (125 MHz, δ ppm, CHCl 3 -d = 77.23 ): 38.72 (CH 2 , C − 1 ), 23.61 (CH 2 , C − 2 ), 81.22 (CH, C − 3 ), 37.05 (C, C − 4 ), 55.54 (CH, C − 5 ), 18.49 (CH 2 , C − 6 ), 33.11 (CH 2 , C − 7 ), 40.27 (C, C − 8 ), 47.88 (CH, C − 9 ), 38.17 (C, C − 10 ), 23.93 (CH 2 , C − 11 ), 124.55 (CH, C − 12 ), 139.84 (C, C − 13 ), 42.31 (C, C − 14 ), 26.84 (CH 2 , C − 15 ), 28.33 (CH 2 , C − 16 ), 33.96 (C, C − 17 ), 59.30 (CH, C − 18 ), 39.83 (CH, C − 19 ), 39.88 (CH, C − 20 ), 31.48 (CH 2 , C − 21 ), 41.76 (CH 2 , C − 22 ), 28.36 (CH 3 , C − 23 ), 17.10 (CH 3 , C − 24 ), 15.97 (CH 3 , C − 25 ), 17.13 (CH 3 , C − 26 ), 23.47 (CH 3 , C − 27 ), 28.97 (CH 3 , C − 28 ), 17.72 (CH 3 , C − 29 ), 21.61 (CH 3 , C − 30 ), 166.97 (C, C − 1' ), 144.46 (CH, C − 2' ), 119.08 (CH, C − 3' ), 134.79 (C, C − 4' ), 128.23 (CH, C − 5'/9' ), 129.03 (CH, C − 6'/8' ), 130.30 (CH, C − 7' ); FTIR (KBr) υ max : 2854.2, 2933.3 (C-H, aliphatic), 1706.9 (C = O), 1634.1 (C = C) cm − 1 . These data agree with the those reported by Akihisa et al. ( 2010 ) and Miranda et al. ( 2000 ) in the literature for α-amyrin cinnamate. Compound 3, sitosterol cinnamate : White powder; ESI-MS: [M + H] + m/z = 545.8512; Molecular formula: C 38 H 56 O 2 ; soluble in CHCl 3 ; 1 H-NMR (500 MHz, δ ppm, CHCl 3 -d = 7.24 ): 7.64 (d, 1H, J = 15.8 Hz, H − 3' ), 7.51 (m, 2H, J = 4.2 Hz, H − 6'/8' ) and 7.50 (1H, H − 7' ), 7.35 (d, 2H, J = 4.9 Hz, H − 5'/9' ), 6.42 (d, 1H, J = 16.0 Hz, H − 2' ), 5.12 (dd, 1H, J = 5.8 Hz, H − 6 ), 3.57 (dd, 1H, H − 3 ), 0.77-1.00 (s, 6×3H); 13 C-NMR (125 MHz, δ ppm, CHCl 3 -d = 77.23 ): 38.23 (CH 2 , C − 1 ), 29.91 (CH 2 , C − 2 ), 71.28 (CH, C − 3 ), 39.72 (CH 2 , C − 4 ), 139.78 (C, C − 5 ), 119.12 (CH, C − 6 ), 29.57 (CH 2 , C − 7 ), 32.10 (CH, C − 8 ), 51.48 (CH, C − 9 ), 34.47 (C, C − 10 ), 21.79 (CH 2 , C − 11 ), 37.40 (CH 2 , C − 12 ), 43.53 (C, C − 13 ), 55.37 (CH, C − 14 ), 23.25 (CH 2 , C − 15 ), 28.71 (CH 2 , C − 16 ), 56.17 (CH, C − 17 ), 12.28 (CH 3 , C − 18 ), 19.23 (CH 3 , C − 19 ), 40.52 (CH, C − 20 ), 21.29 (CH 3 , C − 21 ), 31.71 (CH 2 , C − 22 ), 25.61 (CH 2 , C − 23 ), 49.71 (CH, C − 24 ), 41.01 (CH, C − 25 ), 13.25 (CH 3 , C − 26 ), 21.59 (CH 3 , C − 27 ), 22.90 (CH 2 , C − 28 ), 12.45 (CH 3 , C − 29 ), 167.0 (C, C − 1' ), 144.5 (CH, C − 2' ), 117.6 (CH, C − 3' ), 138.36 (C, C − 4' ), 128.25 (CH, C − 5'/9' ), 129.06 (CH, C − 6'/8' ), 129.06 (CH, C − 7' ); FTIR (KBr) υ max : 2854.2, 2920.1 (aliphatic, C-H), 1706.9 (C = O), 1634.1 (C = C), 1165.8 (C-O) cm − 1 . On the basis of 1 H and 13 C-NMR, MS and FTIR data above and comparison with those reported in the literature (Buxton et al., 2020 ), compound 3 is identified as sitosterol cinnamate. 2.6 Antimicrobial activity 2.6.1 Microbial strains and culture The reference strains of Mycobacterium smegmatis (MC 2155), Escherichia coli (ATCC 25922), Klebsiella aerogenes (ATCC 13882), Staphylococcus aureus (ATCC 25923), Enterobacter cloacae (ATCC 13047), Klebsiella oxytoca (ATCC 8724) and Enterococcus faecalis (ATCC 13047) were received as gifts from the Department of Food and Biotechnology, University of Johannesburg, Doornfontein, South Africa. The strains were subsequently maintained at the microbiology laboratory of the department at -80°C until use. M. smegmatis strain was cultured on Middlebrook 7H11 agar under hygienic conditions, supplemented with 2% (v/v) glycerol and 10% (v/v) oleic acid, albumin, dextrose and catalase, and allowed to grow for 24 h. Middlebrook 7H9 broth was employed for the determination of minimum inhibitory concentrations (MICs) of the compounds on M. smegmatis . Nutrient agar was used for the activation of other bacterial strains. The Mueller-Hinton broth was used for assessing the MIC values of these strains (Kuete et al., 2012 ). 2.6.2 Minimum inhibitory concentrations (MICs) determination MIC was expressed as the smallest concentration of the tested compounds that irreversibly converted the blue dye of resazurin solution into pink and exhibited total inhibition of the growth of bacteria (Eloff, 1999 ) (Table 1 ). The antimicrobial activity of the test compounds was assessed using resazurin micro-titer assay in a 96-well plate against the studied strains as previously described (Kuete et al., 2012 ), with minimal adjustment. Test samples were dissolved in pure dimethyl suphoxide (DMSO) to afford a final concentration of 1.0 mg/ml, and serially diluted (two folds) to afford working concentrations from 1.0 to 0.0313 mg/ml in a 96-well plate to 7H9 broth for M. smegmatis , and Mueller-Hinton broth for other strains. 100 µl of each concentration was seeded with 100 µl of standardized suspension of inoculums (1.5×10 6 CFU/ml) in duplicate under aseptic conditions. The plates were sealed with sterile seals and then incubated at 37°C for 24 h. Viable bacterial cells were confirmed calorimetrically by the addition of resazurin dye (40 µL of 200 µg/mL) after 2 h incubation at 37°C as they enzymatically reduced resazurin dye (blue colour) to the resorufin (pink colour), and remained blue in death cells. Muller-Hilton broth (50% v/v in DMSO) was used as negative control. The concentration of DMSO in the well had no experimental influence on the bacterial growth. Streptomycin and nalidixic acid, two broad-spectrum antibiotics, were used as positive controls. 2.7 in vitro cytotoxicity The compounds were evaluated for their in vitro cytotoxicity against human cervical cancer cell line (HeLa cells) employing MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) assay as described by Parthasarathy and his colleagues ( 2020 ) with minimal adjustment. A fixed concentration (50 µg/ml) of tested samples was prepared in 100% dimethyl sulphoxide (DMSO) and incubated with HeLa cells in 96-well plate (1 × 10 4 cells/mL) cultured and maintained in DMEM with 10% (v/v) fetal bovine serum (FBS) at 37 o C for 1 day in an environment of 5% carbon dioxide. Control cells were supplemented with 100 µl with pure DMSO. The number of HeLa cells that survived the tested samples exposure were determined by employing the resazurin-based reagent, and subsequently reading resorufin fluorescence in a multiwell micro-plate reader (VERSAmax, USA) at 595 nm. The experiments were performed in duplicate, and a mean standard deviation (SD) was calculated for each. The results were expressed as percentage (%) cell viability based on the fluorescence reading in treated wells against untreated control wells (Table 1 ). 3 Results and discussion The present study reports GC-MS analysis and the isolation of bioactive principles of V. paradoxa , a multipurpose medicinal plant used in African traditional medicine for managing respiratory infections, including tuberculosis and cough. GC-MS profiling of the extract revealed the occurrence of a total of 60 peaks of which 48 chemical compounds were identified. The identified compounds with their peak number, retention time (RT), and peak area (%) are presented in Table S1 ( Supplementary Information ) . Out of the 48 detectable chemical constituents in the chromatogram ( Supplementary Information ), the major abundant bioactive compounds include hexadecane (11.23%), tetradecane (7.61%), 1-nonadecene (4.81%), 9-octadecenoic acid, methyl ester, (E)- (4.69%), n-pentadecanol (4.43%), 1-heptacosanol (4.15%), hexadecanoic acid, methyl ester (3.58%), glycidyl oleate (3.55%), and 1-hexadecene (3.34%). In addition, the phytochemicals identified in this present study belong to different classes of compounds, and most of them could be employed as antimicrobial agents ( Table S1 and Fig. 2) . 1-heptacosanol, a long-chain fatty alcohol, is reported as antimicrobial agent against E. coli and S. aureus (Abdi et al., 2020 ). 2-nonenal, (E)- is a phytoconstituent reported from Brownea grandiceps (Jacq.) leaves oils with promising antimycobacterial activity against M. tuberculosis (Korany et al., 2021 ). Hexadecanoic acid, methyl ester was reported to show promising antimicrobial effect against clinical pathogenic bacteria, including Staphylococcus aureus , Pseudomonas aeruginosa , Klebsiella pneumoniae , and K. pneumoniae (Shaaban et al., 2021 ). The presence of these compounds could be one of the reasons for the ethnopharmacological uses of the species in the management of respiratory-related infections. In addition, it could also be linked to these identified lipophilic compounds - hexadecane, tetradecane, and 1-nonadecene among others ( Table S1 ). These lipophilic compounds possess the ability to weaken the binding mechanism of bacterial cell membranes as well as disrupt the membrane balance, which subsequently lead to cytoplasmic leakage and bacterial cell death (Savoia, 2012 ). Similarly, the hexane stem-bark extract was subjected to column chromatography on silica to afford three compounds, including 11-hydroxy β-amyrin cinnamate ( 1 ) (Sirignano et al., 2021 ), α-amyrin cinnamate ( 2 ) (Miranda et al., 2000 ), and sitosterol cinnamate ( 3 ) (Buxton et al., 2020 ) ( Fig. 3 ). The structures of the three compounds were established by analysis of their 1 H, 13 C and 2D-NMR, as well as their mass spectroscopy (Provided in Supplementary List), and by comparison with previously reported data in the literature. Notably, to our knowledge, compounds 2 and 3 are reported here from the stem-bark of the plant for the first time. In order to explore the contribution of compounds 1 – 3 to the ethnobotanical uses of the plant in the treatment of tuberculosis and cough, they were screened against M. smegmatis (used as model for the pathogenic strain M. tuberculosis ) together with six other bacterial pathogens associated with respiratory tract infections (Table 1 ) employing 96-well plate microbroth dilution method, and also investigated the cytotoxicity of compounds with the exception of isolate 3 which was not assessed to due low amount available. Table 1 Antimicrobial and cytotoxicity of tested compounds 1 – 3 from Vitellaria paradoxa Antimicrobial (MIC, mg/mL) Cytotoxicity (IC 50 µg/mL) Strains : Ms Ec Ka Sa Ecl Ko Ef HeLa Compound 1 0.50 0.50 0.50 0.50 0.50 0.50 0.50 82.53 ± 4.06 Compound 2 1.00 0.50 0.50 0.50 1.00 0.50 0.50 77.82 ± 10.5 Compound 3 0.125 0.0625 0.250 0.0625 0.0625 0.0625 0.0625 Not determined Streptomycin 0.004 0.064 0.016 0.256 0.512 0.016 0.128 Nalidixic acid 0.512 0.512 0.256 0.064 0.016 0.008 > 0.512 Ms - Mycobacterium smegmatis ; Ec - Escherischia coli; Ka - Klebsiella aerogenes ; Sa - Staphylococcus aureus ; Ecl - Enterobacter cloacae ; Ko - Klebsiella oxytoca ; Ef - Enterococcus faecalis; HeLa – Human cancer cell line The isolated compounds 1 – 3 pharmacologically showed the antimycobacterial activity, with sitosterol cinnamate ( 3 ) exhibited the best activity against the inhibition of M. smegmatis (MIC; 0.125 mg/ml). It also showed the best activity against other tested bacterial strains, with MICs varying from 0.0625 to 0.25 mg/ml (Table 1 ). When compared with one of the positive controls, compound 3 exhibited better or equal activity to the nalidixic acid against M. smegmatis , E. coli , K. aerogenes , S. aureus , and E. faecalis . It also displayed better or equal activity against E. coli , S. aureus , E. cloacae , and E. faecalis in comparison with streptomycin, an antibiotic for treating tuberculosis. Unarguably, structure dictates functions. Structurally, all the isolates 1 – 3 ( Fig. 3 ) contain cinnamoyl groups at the C-3. It is well-known that cinnamoyl functionality is a component of many drug-like molecules with enhanced biological activities, including antimycobacterial and antimalarial (De et al., 2012 ; Tanachatchairatana et al., 2008 ). Presumably, the better activity of compound 3 might be connected with structural difference to those of 1 and 2 , which mainly consist of triterpenoid skeleton. Meanwhile, in setting clinical benchmark, Gibbons ( 2004 ) defined that a plant extract or its natural product has little clinical relevance if its MIC values greater than 1.0 mg/ml. Thus, compounds 1 – 3 fall under Gibbons' benchmark, and their inhibitory activities against the tested strains are also reported here for the first time. Also, compounds 1 and 2 showed a non-toxicity at the single concentration (50.0 µg/ml ) tested against human cancer cell line (HeLa), with compound 1 had better toxicity profile with IC 50 of 82.53 ± 4.06 µg/ml (Table 1 ). Plant natural products are considered toxic if the IC 50 value ≤ 4 µg/ml (Pezzuto, 2002 ) according to the benchmark by the American National Cancer Institute (NCI). However, it might be erroneous to draw conclusion on the cytotoxicity of the tested compounds. Thus, further studies using normal human cell lines and/or more than one cancer cell lines in in vivo studies would be valuable to unravel the toxicity of these compounds in rational drug design and development against respiratory infection pathogens, including TB. 4 Conclusion The present study reported identification of 48 phytochemicals using GC-MS, and the chromatographic isolation of three compounds, including 11-hydroxy β-amyrin cinnamate ( 1 ), α-amyrin cinnamate ( 2 ), and sitosterol cinnamate ( 3 ) from Vitellaria paradoxa . The compounds 1–3 showed inhibition of M. smegmatis , E. coli , K. aerogenes , S. aureus , E. cloacae , K. oxytoca , and E. faecalis , and their antimicrobial activities are reported here for the first time to our knowledge. Likewise, compounds 2 and 3 are isolated from the stem-bark of the plant for the first time in this study. Antibacterial activities of these compounds could provide some scientific justifications for the ethnomedicinal uses of V. paradoxa in the treatment of respiratory disorders, including tuberculosis. Declarations Conflicts of Interest The authors declare that they have no conflict of interest. Funding This work was supported financially by the South African TWAS-NRF Fellowships (Ref: Grant Numbers 116110 & 139057). Acknowledgement The authors are grateful to the National Research Foundation, South Africa, as well as The World Academy of Sciences, Italy for providing research fund for this work. CRediT authorship contribution statement Olusesan Ojo: Conceptualization, Methodology, Data curation, Data analysis, Writing - original draft, Funding acquisition. Edwin M. Mmutlane: Writing - review & editing, Supervision. Derek T. Ndinteh: Conceptualization, Supervision, Writing - review & editing, Funding acquisition References Abdi, B., Getaneh, E., Gelaw, T., Dekebo, A., Tesso, H., Abdo, T., Melaku, Y., 2020. Chemical constituents of the roots extract of Dryopteris schimperiana and evaluation for antibacterial and radical scavenging activities. Ethiopian Journal of Science and Sustainable Development 7, 2020. https://doi.org/10.20372/ejssdastu:v7.i1.2020.153 Akihisa, T., Kojima, N., Kikuchi, T., Yasukawa, K., Tokuda, H., T. Masters, E., Manosroi, A., Manosroi, J., 2010. Anti-inflammatory and chemopreventive effects of triterpene cinnamates and acetates from Shea Fat. Journal of Oleo Science 59, 273–280. https://doi.org/10.5650/jos.59.273 Ariyo, O.C., Usman, M.B., Olorukooba, M.M., Ariyo, M.O., Suleiman, R., Aasa, O.S., Adetunji, A.J., Oni, O.B., 2020. Ethnobotanical survey of medicinal plants used in the treatment of cough in Akinyele Local Government Area, Oyo State, Nigeria. European Journal of Medicinal Plants 101–113. https://doi.org/10.9734/ejmp/2020/v31i830263 Atanasov, A.G., Zotchev, S.B., Dirsch, V.M., Supuran, C.T., 2021. Natural products in drug discovery: advances and opportunities. Nature Reviews Drug and Discovery 20, 200–216. https://doi.org/10.1038/s41573-020-00114-z Buxton, T., Takahashi, S., Eddy Doh, A.-M., Baffoe-Ansah, J., Owusu, E.O., Kim, C.-S., 2020. Insecticidal activities of cinnamic acid esters isolated from Ocimum gratissimum L. and Vitellaria paradoxa Gaertn leaves against Tribolium castaneum Hebst (Coleoptera: Tenebrionidae). Pest Management Science 76, 257–267. https://doi.org/10.1002/ps.5509 da Costa, A.V., Calábria, L.K., Furtado, F.B., de Gouveia, N.M., Oliveira, R.J. da S., de Oliveira, V.N., Beletti, M.E., Espindola, F.S., 2013. Neuroprotective effects of Pouteria ramiflora (Mart.) Radlk (Sapotaceae) extract on the brains of rats with streptozotocin-induced diabetes. Metabolic Brain Disease 28, 411–419. https://doi.org/10.1007/s11011-013-9390-6 De, P., Bedos-Belval, F., Vanucci-Bacqué, C., Baltas, M., 2012. Cinnamic acid derivatives in tuberculosis, malaria and cardiovascular diseases - A review. Current Organic Chemistry 16, 747–768. https://doi.org/10.2174/138527212799958020 Demissie, B.W., Amele, E.A., Yitayew, Y.A., Yalew, Z.M., 2021. Acute lower respiratory tract infections and associated factors among under-five children visiting Wolaita Sodo University Teaching and Referral Hospital, Wolaita Sodo, Ethiopia. BMC Pediatrics 21, 413. https://doi.org/10.1186/s12887-021-02888-6 Dong, M., Pfeiffer, B., Altmann, K.-H., 2017. Recent developments in natural product-based drug discovery for tuberculosis. Drug Discovery Today 22, 585–591. https://doi.org/10.1016/j.drudis.2016.11.015 Eloff, J., 1999. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Medica 64, 711–3. https://doi.org/10.1055/s-2006-957563 Forum of International Respiratory Societies. European Respiratory Society, 2017. The global impact of respiratory disease - Second edition. Sheffield. pp. 56 -89 Gibbons, S., 2004. Anti-staphylococcal plant natural products. Natural Product Reports 21, 263–77. https://doi.org/10.1039/b212695h Global tuberculosis report 2020. URL https://www.who.int/publications-detail-redirect/9789240013131 (accessed 9.7.21). Husain, M., Valayer, S., Poey, N., Rondinaud, E., d’Humières, C., Visseaux, B., Lariven, S., Lescure, F., Deconinck, L., 2021. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards. Infectious Diseases Now, 1-22. https://doi.org/10.1016/j.idnow.2021.12.001 Ikuta, A., Morikawa, A., 1992. Triterpenes from Stauntonia hexaphylla callus tissues. Journal of Natural Products 55, 1230–1233. https://doi.org/10.1021/np50087a008 Korany, D.A., Ayoub, I.M., Labib, R.M., El-Ahmady, S.H., Singab, A.N.B., 2021. The impact of seasonal variation on the volatile profile of leaves and stems of Brownea grandiceps (Jacq.) with evaluation of their anti-mycobacterial and anti-inflammatory activities. South African Journal of Botany 142, 88–95. https://doi.org/10.1016/j.sajb.2021.06.013 Kuete, V., BetrandTeponno, R., Mbaveng, A.T., Tapondjou, L.A., Meyer, J.J.M., Barboni, L., Lall, N., 2012. Antibacterial activities of the extracts, fractions and compounds from Dioscorea bulbifera . BMC Complementary and Alternative Medicine 12, 228. https://doi.org/10.1186/1472-6882-12-228 Kumatia, E.K., Appiah-Opong, R., 2021. The hydroethanolic stem bark extract of Tieghemella heckelii (A.Chev.) Pierre ex Dubard (Sapotaceae) produced N-methyl-D-aspartate (NMDA) receptor-dependent analgesia and attenuates acute inflammatory pain via disruption of oxidative stress. Evidence-Based Complementary and Alternative Medicine 2021, e3466757. https://doi.org/10.1155/2021/3466757 Lawal, I.O., Olufade, I.I., Rafiu, B.O., Aremu, A.O., 2020. Ethnobotanical survey of plants used for treating cough associated with respiratory conditions in Ede South Local Government Area of Osun State, Nigeria. Plants (Basel) 9, E647. https://doi.org/10.3390/plants9050647 Lee, S.H., Ruan, S.-Y., Pan, S.-C., Lee, T.-F., Chien, J.-Y., Hsueh, P.-R., 2019. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units. Journal of Microbiology, Immunology and Infection 52, 920–928. https://doi.org/10.1016/j.jmii.2019.10.009 McGaw, L.J., Awouafack, M.D., Sakong, B.M., Makhafola, T.J., Hlokwe, T.M., Madoroba, E., Eloff, J.N., 2015. The sapotaceae as a source of antitubercular metabolites and isolation of antimycobacterial pentacyclic triterpenes from Sideroxylon inerme . Planta Medica 81, PW_23. https://doi.org/10.1055/s-0035-1565647 Michaud, C.M., 2009. Global burden of infectious diseases. Encyclopedia of Microbiology 444–454. https://doi.org/10.1016/B978-012373944-5.00185-1 Miranda, A.L.P. de, Silva, J.R.A., Rezende, C.M., Neves, J.S., Parrini, S.C., Pinheiro, M.L.B., Cordeiro, M.C., Tamborini, E., Pinto, A.C., 2000. Anti-Inflammatory and analgesic activities of the latex containing triterpenes from Himatanthus sucuuba . Planta Medica 66, 284–286. https://doi.org/10.1055/s-2000-8572 Mirzayev, F., Viney, K., Linh, N.N., Gonzalez-Angulo, L., Gegia, M., Jaramillo, E., Zignol, M., Kasaeva, T., 2021. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. European Respiratory Journal 57, 1-16 https://doi.org/10.1183/13993003.03300-2020 Nadembega, P., Boussim, J.I., Nikiema, J.B., Poli, F., Antognoni, F., 2011. Medicinal plants in Baskoure, Kourittenga Province, Burkina Faso: An ethnobotanical study. Journal of Ethnopharmacology 133, 378–395. https://doi.org/10.1016/j.jep.2010.10.010 Ogbole, O.O., Ajaiyeoba, E.O., 2009. Traditional management of tuberculosis in Ogun State of Nigeria: the practice and ethnobotanical survey. Africa Journal of Traditional, Complementary and Alternative Medicine 7, 79–84. https://doi.org/10.4314/ajtcam.v7i1.57270 Ojo, O., Kengne, M.H.K., Fotsing, M.C., Mmutlane, E.M., Ndinteh, D.T., 2021. Traditional uses, phytochemistry, pharmacology and other potential applications of Vitellaria paradoxa Gaertn. (Sapotaceae): A review. Arabian Journal of Chemistry 14, 103213. https://doi.org/10.1016/j.arabjc.2021.103213 Parthasarathy, R., Shanmuganathan, R., Pugazhendhi, A., 2020. Vinblastine production by the endophytic fungus Curvularia verruculosa from the leaves of Catharanthus roseus and its in vitro cytotoxicity against HeLa cell line. Analytical Biochemistry 593, 113530. https://doi.org/10.1016/j.ab.2019.113530 Passarelli-Araujo, H., Palmeiro, J.K., Moharana, K.C., Pedrosa-Silva, F., Dalla-Costa, L.M., Venancio, T.M., 2019. Genomic analysis unveils important aspects of population structure, virulence, and antimicrobial resistance in Klebsiella aerogenes . The FEBS Journal 286, 3797–3810. https://doi.org/10.1111/febs.15005 Pezzuto, J.M., 2002. Natural Compounds in Cancer Therapy. Pharmaceutical Biology 40, 79–79. https://doi.org/10.1076/phbi.40.1.79.5858 Porras, G., Chassagne, F., Lyles, J.T., Marquez, L., Dettweiler, M., Salam, A.M., Samarakoon, T., Shabih, S., Farrokhi, D.R., Quave, C.L., 2021. Ethnobotany and the role of plant natural products in antibiotic drug discovery. Chemical Reviews 121, 3495–3560. https://doi.org/10.1021/acs.chemrev.0c00922 Prat, C., Lacoma, A., 2016. Bacteria in the respiratory tract—how to treat? Or do not treat? International Journal of Infectious Diseases 51, 113–122. https://doi.org/10.1016/j.ijid.2016.09.005 Savoia, D., 2012. Plant-derived antimicrobial compounds: alternatives to antibiotics. Future Microbiology 7, 979–990. https://doi.org/10.2217/fmb.12.68 Shaaban, M.T., Ghaly, M.F., Fahmi, S.M., 2021. Antibacterial activities of hexadecanoic acid methyl ester and green-synthesized silver nanoparticles against multidrug-resistant bacteria. Journal of Basic Microbiology 61, 557–568. https://doi.org/10.1002/jobm.202100061 Sirignano, C., Nadembega, P., Poli, F., Romano, B., Lucariello, G., Rigano, D., Taglialatela-Scafati, O., 2021. Triterpenoids from Vitellaria paradoxa stem barks reduce nitrite levels in LPS-stimulated macrophages. Plants 10, 1006. https://doi.org/10.3390/plants10051006 Tanachatchairatana, T., Bremner, J.B., Chokchaisiri, R., Suksamrarn, A., 2008. Antimycobacterial activity of cinnamate-based esters of the triterpenes betulinic, oleanolic and ursolic acids. Chemical and Pharmaceutical Bulletin 56, 194–198. https://doi.org/10.1248/cpb.56.194 Yoo, I.Y., Huh, K., Shim, H.J., Yun, S.A., Chung, Y.N., Kang, O.K., Huh, H.J., Lee, N.Y., 2020. Evaluation of the BioFire FilmArray Pneumonia Panel for rapid detection of respiratory bacterial pathogens and antibiotic resistance genes in sputum and endotracheal aspirate specimens. International Journal of Infectious Diseases 95, 326–331. https://doi.org/10.1016/j.ijid.2020.03.024 Zhong, Q., Feng, H., Lu, Q., Liu, X., Zhao, Q., Du, Y., Zhang, X.-H., Wang, J.-R., 2018. Recurrent wheezing in neonatal pneumonia is associated with combined infection with respiratory syncytial virus and Staphylococcus aureus or Klebsiella pneumoniae . Scientific Reports 8, 995. https://doi.org/10.1038/s41598-018-19386-y Additional Declarations The authors declare no competing interests. Supplementary Files Supplementarymaterials.docx Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3967817","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":273545853,"identity":"ec59399a-e66c-4876-ad1a-4313fc6d75e6","order_by":0,"name":"Olusesan Ojo","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA9UlEQVRIiWNgGAWjYFCCAwwMDyAs5ocfKkAUcwNhLQkQFpuxxBmQFkZCWhjgWhgkeNtAFAEt/IyHDz5IbKuTk28/e8BAcl5tNH87UMuPim04tUg2HEs2SGw7bGxwJi/hQeG247kzDjM2MPacuY1Ti8GBM2YSiW0HEjcw5BgYSG47ltsA1MLM2EZQS139/P43BhK8c47lzidSC3MCw40coJaGmtwNhLSA/ZJw7rDhhhtvzIwljh3I3QjUchCfX/glgCH2oaxOXr4/x/jhh5q63HnngSI/KnBrYZA4gMI9DCYPYKpDtqYBhVuHV/EoGAWjYBSMTAAAJ6xhIncI634AAAAASUVORK5CYII=","orcid":"https://orcid.org/0000-0002-5898-8459","institution":"Centre for Natural Product Research (CNPR), Chemical Sciences Department, University of Johannesburg, Doornfontein, Johannesburg 2028, South Africa","correspondingAuthor":true,"prefix":"","firstName":"Olusesan","middleName":"","lastName":"Ojo","suffix":""},{"id":273545854,"identity":"13c0e31d-5f67-48ed-978e-6cf27f72b3c4","order_by":1,"name":"Edwin M. Mmutlane","email":"","orcid":"","institution":"Research Centre for Synthesis and Catalysis, Department of Chemical Sciences, University of Johannesburg, Kingsway Campus, Auckland Park, P.O. Box 524, Johannesburg, South Africa","correspondingAuthor":false,"prefix":"","firstName":"Edwin","middleName":"M.","lastName":"Mmutlane","suffix":""},{"id":273545855,"identity":"6979137c-2cf3-4d50-b025-da3644fbd253","order_by":2,"name":"Derek T. Ndinteh","email":"","orcid":"","institution":"Centre for Natural Product Research (CNPR), Chemical Sciences Department, University of Johannesburg, Doornfontein, Johannesburg 2028, South Africa","correspondingAuthor":false,"prefix":"","firstName":"Derek","middleName":"T.","lastName":"Ndinteh","suffix":""}],"badges":[],"createdAt":"2024-02-18 19:28:00","currentVersionCode":1,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-3967817/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3967817/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":51379790,"identity":"f5aeb14b-e6dc-4fac-b56d-8a8f9d147817","added_by":"auto","created_at":"2024-02-20 15:17:13","extension":"jpeg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":44793,"visible":true,"origin":"","legend":"\u003cp\u003ePicture of \u003cem\u003eVitellaria paradoxa \u003c/em\u003eshowing its leaves and fruits (Image taking by O.O)\u003c/p\u003e","description":"","filename":"floatimage1.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-3967817/v1/c6fef21929585e86d2e96b9b.jpeg"},{"id":51379789,"identity":"7f9c746e-9d69-445f-8b0a-00d16881681b","added_by":"auto","created_at":"2024-02-20 15:17:13","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":256779,"visible":true,"origin":"","legend":"\u003cp\u003eChemical structures of some identified compounds of pharmacological interest from \u003cem\u003eVitellaria paradoxa \u003c/em\u003estem-bark extract\u003c/p\u003e","description":"","filename":"2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-3967817/v1/72d3a0cc8e396ea7deec48b9.jpg"},{"id":51379791,"identity":"f7cc23c1-c420-4674-9321-f676d00f9907","added_by":"auto","created_at":"2024-02-20 15:17:13","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":194265,"visible":true,"origin":"","legend":"\u003cp\u003eChemical structures of compounds \u003cstrong\u003e1\u003c/strong\u003e-\u003cstrong\u003e3 \u003c/strong\u003eisolated from \u003cem\u003eVitellaria paradoxa\u003c/em\u003e\u003c/p\u003e","description":"","filename":"3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-3967817/v1/9a1f5a446ac706476a2a235f.jpg"},{"id":51380084,"identity":"a554ee2e-80b2-45b5-870e-dcedd98ffac6","added_by":"auto","created_at":"2024-02-20 15:25:18","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":556973,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3967817/v1/220ea2b4-ee2e-47d1-9f42-07ec01fc6128.pdf"},{"id":51379794,"identity":"5371475e-2da5-4ccd-b593-691e601f1beb","added_by":"auto","created_at":"2024-02-20 15:17:24","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":6007558,"visible":true,"origin":"","legend":"","description":"","filename":"Supplementarymaterials.docx","url":"https://assets-eu.researchsquare.com/files/rs-3967817/v1/4bfa5013a64c0421ba814ad5.docx"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"\u003cp\u003e\u003cstrong\u003eInhibitory Activity of Chemical Constituents from \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eVitellaria paradoxa\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e Gaertn. (Sapotaceae) Against Pathogens Associated with Respiratory Tract Infections\u003c/strong\u003e\u003c/p\u003e","fulltext":[{"header":"1 Introduction","content":"\u003cp\u003eRespiratory tract infections (RTIs), such as pneumonia impose immense health burden in the world, accounting for over four millions fatalities yearly (Forum of International Respiratory Societies and European Respiratory Society, \u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e2017\u003c/span\u003e). It is particularly a leading cause of death among children within the age of 5 years than older children or adults in developing countries. It is estimated that over 2\u0026nbsp;million children within this age group die due to pneumonia in developing nations, and over 43% of global death rates from acute RTIs are linked to developing countries, including Nigeria, Ethiopia, Democratic Republic Congo (Demissie et al., \u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e2021\u003c/span\u003e). These figures do not include the over 1.2\u0026nbsp;million deaths recorded as due to tuberculosis (TB), which is another fatal respiratory-cum-lung infection (WHO, 2020). Together, respiratory tract infections and tuberculosis are two significant contributors to the incessant rising in the global burden of communicable diseases (Michaud, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e2009\u003c/span\u003e). Despite significant breakthroughs in the rollout of antibiotics to curb the menace of these infections over the past decades, there are still the problem of antimicrobial resistance in addition to the adverse effects of these antibiotics on the host-like hypersensitivity. Drug-resistant bacterial infections are on the increase worldwide, and this has called for continued surveillance and desperate search for new drug pipelines against menace of tuberculosis and other bacterial pathogens associated with respiratory infections, including methicillin-resistant \u003cem\u003eStaphylococcus aureus\u003c/em\u003e (MRSA), \u003cem\u003ePseudomonas aeruginosa\u003c/em\u003e, \u003cem\u003eEnterococcus faecalis\u003c/em\u003e, \u003cem\u003eKlebsiella oxytoca\u003c/em\u003e, \u003cem\u003eEscherichia coli\u003c/em\u003e, \u003cem\u003eKlebsiella aerogenes\u003c/em\u003e, and \u003cem\u003eEnterobacter cloacae\u003c/em\u003e (Mirzayev et al., \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e2021\u003c/span\u003e; Prat and Lacoma, \u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e2016\u003c/span\u003e; Yoo et al., \u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e2020\u003c/span\u003e; Husain et al., \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e2021\u003c/span\u003e; Passarelli-Araujo et al., \u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e2019\u003c/span\u003e; Lee et al., \u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e2019\u003c/span\u003e; Zhong et al., \u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e2018\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eNatural products have historically been acting as an invaluable source of therapeutical agents in many disease areas, very much in the area of infections due to pathogenic bacteria (Atanasov et al., \u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e2021\u003c/span\u003e). In fact, they have been at the origin of many clinically used drugs, such as streptomycin and rifamycin against tuberculosis and other related infections (Dong et al., \u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e2017\u003c/span\u003e). Natural plant-based drugs could serve as anti-infective agents with novel modes of actions (Porras et al., \u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e2021\u003c/span\u003e). Many plant species in the family Sapotaceae have been reported to possess several pharmacological activities, including antimycobacterial (da Costa et al., \u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e2013\u003c/span\u003e; Kumatia and Appiah-Opong, \u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e2021\u003c/span\u003e; McGaw et al., \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e2015\u003c/span\u003e). The species \u003cem\u003eVitellaria paradoxa\u003c/em\u003e Gaertn. (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003e\u003cb\u003e)\u003c/b\u003e is a widely distributed medicinal plant in sub-Sahara Africa that has been traditionally used in the treatment of respiratory tract infections and related symptoms, including tuberculosis (Ogbole and Ajaiyeoba, \u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e2009\u003c/span\u003e), bronchitis, coughs and whooping cough (Ariyo et al., \u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e2020\u003c/span\u003e; Lawal et al., \u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e2020\u003c/span\u003e), and lung disorders (Nadembega et al., \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e2011\u003c/span\u003e). It has been reported to possess antioxidant, anti-inflammatory, anticancer (Ojo et al., \u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e2021\u003c/span\u003e), antidiarrhoeal, and insecticidal activities (Buxton et al., \u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e2020\u003c/span\u003e). Prior phytochemical investigation led to the identification of Androseptoside A, Lupeol acetate (Akihisa et al. \u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2010\u003c/span\u003e), gallic acid, ferulic acid, and rutin (Ojo et al., \u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e2021\u003c/span\u003e). However, little is known about its anti-infective potential against causative agents of respiratory infections. The present study, thus, described GC-MS metabolites profiling of \u003cem\u003eV. paradoxa\u003c/em\u003e, and the chromatographic isolation of cinnamoyl compounds from the hexane extract. The study also described the pharmacological activities of the isolated compounds against \u003cem\u003eMycobacterium smegmatis\u003c/em\u003e which is used as \u0026ldquo;surrogate\u0026rdquo; model for the virulent \u003cem\u003eMycobacterium tuberculosis\u003c/em\u003e, together with six respiratory-tract-associated bacterial pathogens, including \u003cem\u003eEscherichia coli\u003c/em\u003e, \u003cem\u003eKlebsiella aerogenes\u003c/em\u003e, \u003cem\u003eStaphylococcus aureus\u003c/em\u003e, \u003cem\u003eEnterobacter cloacae\u003c/em\u003e, \u003cem\u003eKlebsiella oxytoca\u003c/em\u003e, and \u003cem\u003eEnterococcus faecalis\u003c/em\u003e.\u003c/p\u003e"},{"header":"2 Materials and methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003e2.1 General instrumentations\u003c/h2\u003e \u003cp\u003eBrucker Avance III NMR spectrometer was used to record the \u003csup\u003e1\u003c/sup\u003eH (frequency; 500 MHz), \u003csup\u003e13\u003c/sup\u003eC (frequency; 125 MHz) and 2D-NMR spectra of the isolated compounds using tetramethylsilane (TMS) as internal standard. Also, deuterated chloroform (d-CHCl\u003csub\u003e3\u003c/sub\u003e) was employed as solvent for running the NMR analysis. Mass spectra were done and recorded on a Brucker Compact mass spectrometer (University of the Witwatersrand, South Africa). IR was performed using Perkin Elmer FTIR 600 series. Column chromatography was performed using column (3 cm \u0026times; 55 cm) with silica gel (mesh size; 60\u0026ndash;120). Thin-layer chromatography (TLC) analysis was carried out on pre-coated silica gel 60 F\u003csub\u003e254\u003c/sub\u003e plates (Macherey-Nagel GmbH \u0026amp; Co. KG) with layer thickness of 0.20 mm. The plates were treated with \u003cem\u003ep\u003c/em\u003e-anisaldehyde-sulphuric acid reagent, and visualized under UV light (254 and 365 nm). Chemicals used in the experiment were purchased from Sigma-Aldrich, South Africa.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec4\" class=\"Section2\"\u003e \u003ch2\u003e2.2 Plant material collection\u003c/h2\u003e \u003cp\u003eThe \u003cem\u003eV. paradoxa\u003c/em\u003e (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003e\u003cb\u003e)\u003c/b\u003e stem-bark sample was collected from the University of Ibadan, Oyo State, Western Nigeria (Geographical location: 7\u003csup\u003eo\u003c/sup\u003e 23̛ 28N 3\u003csup\u003eo\u003c/sup\u003e 54̛ 60E) during the month of September, 2019. The plant sample was identified and authenticated taxonomically by Mr. D. P. O. Esimekhuai, a Chief Plant Technologist at the Botany Department, University of Ibadan, Nigeria. The voucher specimen, UIH-22897, has been deposited in the same department. The stem-bark sample was thoroughly washed and air-dried for two weeks in an open shaded place at room temperature. The air-dried samples were milled into fine powder with the aid of an industrial grinder and kept in a sealed polythene bag until further use at room temperature.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec5\" class=\"Section2\"\u003e \u003ch2\u003e2.3 Extraction\u003c/h2\u003e \u003cp\u003e500 g of \u003cem\u003eV. paradoxa\u003c/em\u003e stem-bark was extracted (5 times) with \u003cem\u003en\u003c/em\u003e-hexane (1 L) at room temperature for 24 hrs. The extract was concentrated after filtration using a rotary evaporator under reduced pressure at 40 \u003csup\u003eo\u003c/sup\u003eC to give a yellowish waxy substance.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003e2.4 GC-MS analysis\u003c/h2\u003e \u003cp\u003eThe hexane crude extract was subjected to GC-MS analysis after dissolving in HPLC-grade methanol and filtering through a 0.2 \u0026micro;m PTFE syringe-driven filter into GC-MS vials. The GC-MS instrument Agilent Technologies (GC-7890B: MS-5977AMSB) was employed in the analysis of the extract. The injector temperature was set at 290 \u003csup\u003e0\u003c/sup\u003eC, while column oven temperature was set at 50\u0026deg;C to 150\u0026deg;C at 3\u0026deg;C/min, then held isothermal for 10 min and finally raised to 300\u0026deg;C at 10\u0026deg;C/min. The sample injection was 1 \u0026#120583;L. Carrier gas was pure Helium gas (99.9%) 1 ml/min in a splitless mode. The total GC run time was 19 mins with a mass detector. The ion source temperature was set at 350\u0026deg;C with ionization voltage of 70 eV. The inlet temperature was 250\u0026deg;C, with solvent delay of 10 mins. The mass scan (m/z) was run from 40 to 1000 amu. The identification of the phytochemicals present in the crude extract was achieved by comparing their spectra with the spectra fingerprint of the known compounds in the curated database of National Institute Standard and Technology, NIST version\u0026mdash;2011. The name, molecular formula, molecular weight, and chemical structure of the phytochemicals in the analyzed extract were identified (\u003cb\u003eTable\u003c/b\u003e \u003cb\u003eS1\u003c/b\u003e) provided in Supplementary List. Relative quantity of the phytochemicals presents in the stem-bark extract of \u003cem\u003eV. paradoxa\u003c/em\u003e were individually expressed as percentage (%) based on peak areas produced in the chromatogram.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec7\" class=\"Section2\"\u003e \u003ch2\u003e2.5 Column chromatographic isolation\u003c/h2\u003e \u003cp\u003e10 g of the crude extract was fractionated using gradient elution [starting from hexane (100%), with 10% increase in chloroform to 100% chloroform] on silica gel column (3 cm \u0026times; 55 cm) to yield twelve fractions (VPH 1- VPH 10) on the basis of their thin-layer chromatography (TLC) profiles. All fractions were screened against \u003cem\u003eMycobacterium smegmatis\u003c/em\u003e to evaluate their \u003cem\u003ein vitro\u003c/em\u003e antimycobacterial activity using micro-dilution technique. The most bioactive fractions VPH 6 (109.5 mg), VPH 7 (2.20 g), and VPH 10 (220.9 mg) were subjected to further fractionation. Fraction VPH 6 was re-chromatographed on silica gel column, eluting with hexane-ethyl acetate (1:9 to 0:10) as mobile phase to yield four sub-fractions VPH 6A-D. The sub-fraction VPH 6A appeared as a white solid substance was recrystallized from dichloromethane/methanol to give compound \u003cb\u003e1\u003c/b\u003e (11-hydroxy β-amyrin cinnamate, 15.4 mg\u003cb\u003e)\u003c/b\u003e. Fraction VPH 7 was further purified on silica gel column (mobile phase: hexanes-ethyl acetate 97:3 to 10:90) to give three sub-fractions VPH 7A-C. The sub-fraction VPH 7A gave compound \u003cb\u003e2\u003c/b\u003e (α-amyrin cinnamate, 26.2 mg) after recrystallization from dichloromethane/methanol. Sub-fraction VPH 7B was subjected to further purification to give additional quantity of amyrin cinnamate (9.7 mg). Fraction VPH 10 was chromatographed on silica gel column (mobile phase: hexanes-ethyl acetate 85:15 to 10:90) to give three sub-fractions VPH 10 A-C. Sub-fraction VPH 10C (22.10 mg) after recrystallization from dichloromethane/methanol gave compound \u003cb\u003e3\u003c/b\u003e (sitosterol cinnamate, 9. 6 mg). The structures of the compounds \u003cb\u003e1\u0026ndash;3\u003c/b\u003e were unambiguously elucidated on the basis of their obtained physical and spectroscopic data as well as comparison with those published in the literature.\u003c/p\u003e \u003cp\u003e \u003cb\u003eCompound 1, 11-hydroxy β-amyrin cinnamate\u003c/b\u003e: White powder; ESI-MS: [M\u0026thinsp;+\u0026thinsp;H]\u003csup\u003e+\u003c/sup\u003e \u003cem\u003em/z\u003c/em\u003e\u0026thinsp;=\u0026thinsp;573.3100; MF: C\u003csub\u003e39\u003c/sub\u003eH\u003csub\u003e56\u003c/sub\u003eO\u003csub\u003e3\u003c/sub\u003e; soluble in CHCl\u003csub\u003e3\u003c/sub\u003e; \u003csup\u003e1\u003c/sup\u003eH-NMR (500 MHz, δ ppm, CHCl\u003csub\u003e3\u003c/sub\u003e-d\u0026thinsp;=\u0026thinsp;7.24 ): 7.64 (d, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;15.9 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;3'\u003c/sub\u003e), 7.51 (m, 2H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;4.2 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;6'/8'\u003c/sub\u003e) and 7.50 (1H, H\u003csub\u003e\u0026minus;\u0026thinsp;7'\u003c/sub\u003e), 7.35 (d, 2H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;4.9 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;5'/9'\u003c/sub\u003e), 6.44 (d, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;10.0 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;2'\u003c/sub\u003e), 5.56 (dd, 1H, H\u003csub\u003e\u0026minus;\u0026thinsp;12\u003c/sub\u003e), 4.62 (dd, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;9.80 and 5.3 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;3\u003c/sub\u003e), 4.10 (t, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;3.5 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;11\u003c/sub\u003e), 0.77\u0026ndash;1.03 (s, 8\u0026times;3H); \u003csup\u003e13\u003c/sup\u003eC-NMR (125 MHz, δ ppm, CHCl\u003csub\u003e3\u003c/sub\u003e-d\u0026thinsp;=\u0026thinsp;77.23 ): 38.75 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;1\u003c/sub\u003e), 23.96 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;2\u003c/sub\u003e), 80.85 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;3\u003c/sub\u003e), 37.09 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;4\u003c/sub\u003e), 55.58 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;5\u003c/sub\u003e), 18.51 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;6\u003c/sub\u003e), 32.17 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;7\u003c/sub\u003e), 42.32 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;8\u003c/sub\u003e), 47.92 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;9\u003c/sub\u003e), 39.89 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;10\u003c/sub\u003e), 81.27 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;11\u003c/sub\u003e), 124.59 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;12\u003c/sub\u003e), 139.88 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;13\u003c/sub\u003e), 42.35 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;14\u003c/sub\u003e), 26.87 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;15\u003c/sub\u003e), 28.37 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;16\u003c/sub\u003e), 33.15 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;17\u003c/sub\u003e), 59.34 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;18\u003c/sub\u003e), 41.79 ( CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;19\u003c/sub\u003e), 31.50 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;20\u003c/sub\u003e), 34.00 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;21\u003c/sub\u003e), 40.31 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;22\u003c/sub\u003e), 28.98 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;23\u003c/sub\u003e), 15.99 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;24\u003c/sub\u003e), 14.33 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;25\u003c/sub\u003e), 17.14 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;26\u003c/sub\u003e), 25.40 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;27\u003c/sub\u003e), 28.98 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;28\u003c/sub\u003e), 17.74 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;29\u003c/sub\u003e), 22.93 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;30\u003c/sub\u003e), 167.02 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;1'\u003c/sub\u003e), 144.48 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;2'\u003c/sub\u003e), 119.13 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;3'\u003c/sub\u003e), 134.84 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;4'\u003c/sub\u003e), 128.26 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;5'/9'\u003c/sub\u003e), 129.07 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;6'/8'\u003c/sub\u003e), 130.33 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;7'\u003c/sub\u003e). These data supports those reported for 11α-hydroxy-β-amyrin by Ikuta and Morikawa (\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e1992\u003c/span\u003e) and its cinnamate by Sirignano et al. (\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e2021\u003c/span\u003e) in the literature.\u003c/p\u003e \u003cp\u003e \u003cb\u003eCompound 2, α-amyrin cinnamate\u003c/b\u003e: White solid powder; ESI-MS: [M\u0026thinsp;+\u0026thinsp;H]\u003csup\u003e+\u003c/sup\u003e \u003cem\u003em/z\u003c/em\u003e\u0026thinsp;=\u0026thinsp;557.4117; MF: C\u003csub\u003e39\u003c/sub\u003eH\u003csub\u003e56\u003c/sub\u003eO\u003csub\u003e2\u003c/sub\u003e; m.p\u0026thinsp;=\u0026thinsp;231\u0026ndash;235 (uncorrected); soluble in CHCl\u003csub\u003e3\u003c/sub\u003e; \u003csup\u003e1\u003c/sup\u003eH-NMR (500 MHz, δ ppm, CHCl\u003csub\u003e3\u003c/sub\u003e-d\u0026thinsp;=\u0026thinsp;7.24 ): 7.64 (d, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;16.0 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;3'\u003c/sub\u003e), 7.52 (m, 2H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;3.95 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;6'/8'\u003c/sub\u003e) and 7.50 (1H, H\u003csub\u003e\u0026minus;\u0026thinsp;7'\u003c/sub\u003e), 7.35 (d, 2H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;4.15 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;5'/9'\u003c/sub\u003e), 6.42 (d, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;16.0 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;2'\u003c/sub\u003e), 5.76 (dd, 1H, H\u003csub\u003e\u0026minus;\u0026thinsp;12\u003c/sub\u003e), 4.61 (dd, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;9.80 and 6.30 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;3\u003c/sub\u003e), 0.76\u0026ndash;1.20 (s, 8\u0026times;3H); \u003csup\u003e13\u003c/sup\u003eC-NMR (125 MHz, δ ppm, CHCl\u003csub\u003e3\u003c/sub\u003e-d\u0026thinsp;=\u0026thinsp;77.23 ): 38.72 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;1\u003c/sub\u003e), 23.61 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;2\u003c/sub\u003e), 81.22 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;3\u003c/sub\u003e), 37.05 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;4\u003c/sub\u003e), 55.54 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;5\u003c/sub\u003e), 18.49 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;6\u003c/sub\u003e), 33.11 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;7\u003c/sub\u003e), 40.27 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;8\u003c/sub\u003e), 47.88 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;9\u003c/sub\u003e), 38.17 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;10\u003c/sub\u003e), 23.93 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;11\u003c/sub\u003e), 124.55 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;12\u003c/sub\u003e), 139.84 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;13\u003c/sub\u003e), 42.31 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;14\u003c/sub\u003e), 26.84 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;15\u003c/sub\u003e), 28.33 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;16\u003c/sub\u003e), 33.96 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;17\u003c/sub\u003e), 59.30 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;18\u003c/sub\u003e), 39.83 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;19\u003c/sub\u003e), 39.88 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;20\u003c/sub\u003e), 31.48 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;21\u003c/sub\u003e), 41.76 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;22\u003c/sub\u003e), 28.36 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;23\u003c/sub\u003e), 17.10 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;24\u003c/sub\u003e), 15.97 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;25\u003c/sub\u003e), 17.13 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;26\u003c/sub\u003e), 23.47 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;27\u003c/sub\u003e), 28.97 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;28\u003c/sub\u003e), 17.72 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;29\u003c/sub\u003e), 21.61 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;30\u003c/sub\u003e), 166.97 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;1'\u003c/sub\u003e), 144.46 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;2'\u003c/sub\u003e), 119.08 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;3'\u003c/sub\u003e), 134.79 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;4'\u003c/sub\u003e), 128.23 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;5'/9'\u003c/sub\u003e), 129.03 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;6'/8'\u003c/sub\u003e), 130.30 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;7'\u003c/sub\u003e); FTIR (KBr) \u003cem\u003eυ\u003c/em\u003e\u003csub\u003emax\u003c/sub\u003e: 2854.2, 2933.3 (C-H, aliphatic), 1706.9 (C\u0026thinsp;=\u0026thinsp;O), 1634.1 (C\u0026thinsp;=\u0026thinsp;C) cm\u003csup\u003e\u0026minus;\u0026thinsp;1\u003c/sup\u003e. These data agree with the those reported by Akihisa et al. (\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2010\u003c/span\u003e) and Miranda et al. (\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e2000\u003c/span\u003e) in the literature for α-amyrin cinnamate.\u003c/p\u003e \u003cp\u003e \u003cb\u003eCompound 3, sitosterol cinnamate\u003c/b\u003e: White powder; ESI-MS: [M\u0026thinsp;+\u0026thinsp;H]\u003csup\u003e+\u003c/sup\u003e \u003cem\u003em/z\u003c/em\u003e\u0026thinsp;=\u0026thinsp;545.8512; Molecular formula: C\u003csub\u003e38\u003c/sub\u003eH\u003csub\u003e56\u003c/sub\u003eO\u003csub\u003e2\u003c/sub\u003e; soluble in CHCl\u003csub\u003e3\u003c/sub\u003e; \u003csup\u003e1\u003c/sup\u003eH-NMR (500 MHz, δ ppm, CHCl\u003csub\u003e3\u003c/sub\u003e-d\u0026thinsp;=\u0026thinsp;7.24 ): 7.64 (d, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;15.8 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;3'\u003c/sub\u003e), 7.51 (m, 2H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;4.2 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;6'/8'\u003c/sub\u003e) and 7.50 (1H, H\u003csub\u003e\u0026minus;\u0026thinsp;7'\u003c/sub\u003e), 7.35 (d, 2H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;4.9 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;5'/9'\u003c/sub\u003e), 6.42 (d, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;16.0 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;2'\u003c/sub\u003e), 5.12 (dd, 1H, \u003cem\u003eJ\u003c/em\u003e\u0026thinsp;=\u0026thinsp;5.8 Hz, H\u003csub\u003e\u0026minus;\u0026thinsp;6\u003c/sub\u003e), 3.57 (dd, 1H, H\u003csub\u003e\u0026minus;\u0026thinsp;3\u003c/sub\u003e), 0.77-1.00 (s, 6\u0026times;3H); \u003csup\u003e13\u003c/sup\u003eC-NMR (125 MHz, δ ppm, CHCl\u003csub\u003e3\u003c/sub\u003e-d\u0026thinsp;=\u0026thinsp;77.23 ): 38.23 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;1\u003c/sub\u003e), 29.91 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;2\u003c/sub\u003e), 71.28 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;3\u003c/sub\u003e), 39.72 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;4\u003c/sub\u003e), 139.78 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;5\u003c/sub\u003e), 119.12 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;6\u003c/sub\u003e), 29.57 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;7\u003c/sub\u003e), 32.10 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;8\u003c/sub\u003e), 51.48 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;9\u003c/sub\u003e), 34.47 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;10\u003c/sub\u003e), 21.79 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;11\u003c/sub\u003e), 37.40 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;12\u003c/sub\u003e), 43.53 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;13\u003c/sub\u003e), 55.37 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;14\u003c/sub\u003e), 23.25 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;15\u003c/sub\u003e), 28.71 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;16\u003c/sub\u003e), 56.17 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;17\u003c/sub\u003e), 12.28 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;18\u003c/sub\u003e), 19.23 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;19\u003c/sub\u003e), 40.52 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;20\u003c/sub\u003e), 21.29 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;21\u003c/sub\u003e), 31.71 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;22\u003c/sub\u003e), 25.61 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;23\u003c/sub\u003e), 49.71 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;24\u003c/sub\u003e), 41.01 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;25\u003c/sub\u003e), 13.25 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;26\u003c/sub\u003e), 21.59 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;27\u003c/sub\u003e), 22.90 (CH\u003csub\u003e2\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;28\u003c/sub\u003e), 12.45 (CH\u003csub\u003e3\u003c/sub\u003e, C\u003csub\u003e\u0026minus;\u0026thinsp;29\u003c/sub\u003e), 167.0 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;1'\u003c/sub\u003e), 144.5 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;2'\u003c/sub\u003e), 117.6 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;3'\u003c/sub\u003e), 138.36 (C, C\u003csub\u003e\u0026minus;\u0026thinsp;4'\u003c/sub\u003e), 128.25 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;5'/9'\u003c/sub\u003e), 129.06 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;6'/8'\u003c/sub\u003e), 129.06 (CH, C\u003csub\u003e\u0026minus;\u0026thinsp;7'\u003c/sub\u003e); FTIR (KBr) \u003cem\u003eυ\u003c/em\u003e\u003csub\u003emax\u003c/sub\u003e: 2854.2, 2920.1 (aliphatic, C-H), 1706.9 (C\u0026thinsp;=\u0026thinsp;O), 1634.1 (C\u0026thinsp;=\u0026thinsp;C), 1165.8 (C-O) cm\u003csup\u003e\u0026minus;\u0026thinsp;1\u003c/sup\u003e. On the basis of \u003csup\u003e1\u003c/sup\u003eH and \u003csup\u003e13\u003c/sup\u003eC-NMR, MS and FTIR data above and comparison with those reported in the literature (Buxton et al., \u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e2020\u003c/span\u003e), compound 3 is identified as sitosterol cinnamate.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003e2.6 Antimicrobial activity\u003c/h2\u003e \u003cdiv id=\"Sec9\" class=\"Section3\"\u003e \u003ch2\u003e2.6.1 Microbial strains and culture\u003c/h2\u003e \u003cp\u003eThe reference strains of \u003cem\u003eMycobacterium smegmatis\u003c/em\u003e (MC 2155), \u003cem\u003eEscherichia coli\u003c/em\u003e (ATCC 25922), \u003cem\u003eKlebsiella aerogenes\u003c/em\u003e (ATCC 13882), \u003cem\u003eStaphylococcus aureus\u003c/em\u003e (ATCC 25923), \u003cem\u003eEnterobacter cloacae\u003c/em\u003e (ATCC 13047), \u003cem\u003eKlebsiella oxytoca\u003c/em\u003e (ATCC 8724) and \u003cem\u003eEnterococcus faecalis\u003c/em\u003e (ATCC 13047) were received as gifts from the Department of Food and Biotechnology, University of Johannesburg, Doornfontein, South Africa. The strains were subsequently maintained at the microbiology laboratory of the department at -80\u0026deg;C until use. \u003cem\u003eM. smegmatis\u003c/em\u003e strain was cultured on Middlebrook 7H11 agar under hygienic conditions, supplemented with 2% (v/v) glycerol and 10% (v/v) oleic acid, albumin, dextrose and catalase, and allowed to grow for 24 h. Middlebrook 7H9 broth was employed for the determination of minimum inhibitory concentrations (MICs) of the compounds on \u003cem\u003eM. smegmatis\u003c/em\u003e. Nutrient agar was used for the activation of other bacterial strains. The Mueller-Hinton broth was used for assessing the MIC values of these strains (Kuete et al., \u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e2012\u003c/span\u003e).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec10\" class=\"Section3\"\u003e \u003ch2\u003e2.6.2 Minimum inhibitory concentrations (MICs) determination\u003c/h2\u003e \u003cp\u003eMIC was expressed as the smallest concentration of the tested compounds that irreversibly converted the blue dye of resazurin solution into pink and exhibited total inhibition of the growth of bacteria (Eloff, \u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e1999\u003c/span\u003e) (Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e). The antimicrobial activity of the test compounds was assessed using resazurin micro-titer assay in a 96-well plate against the studied strains as previously described (Kuete et al., \u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e2012\u003c/span\u003e), with minimal adjustment. Test samples were dissolved in pure dimethyl suphoxide (DMSO) to afford a final concentration of 1.0 mg/ml, and serially diluted (two folds) to afford working concentrations from 1.0 to 0.0313 mg/ml in a 96-well plate to 7H9 broth for \u003cem\u003eM. smegmatis\u003c/em\u003e, and Mueller-Hinton broth for other strains. 100 \u0026micro;l of each concentration was seeded with 100 \u0026micro;l of standardized suspension of inoculums (1.5\u0026times;10\u003csup\u003e6\u003c/sup\u003e CFU/ml) in duplicate under aseptic conditions. The plates were sealed with sterile seals and then incubated at 37\u0026deg;C for 24 h. Viable bacterial cells were confirmed calorimetrically by the addition of resazurin dye (40 \u0026micro;L of 200 \u0026micro;g/mL) after 2 h incubation at 37\u0026deg;C as they enzymatically reduced resazurin dye (blue colour) to the resorufin (pink colour), and remained blue in death cells. Muller-Hilton broth (50% v/v in DMSO) was used as negative control. The concentration of DMSO in the well had no experimental influence on the bacterial growth. Streptomycin and nalidixic acid, two broad-spectrum antibiotics, were used as positive controls.\u003c/p\u003e \u003c/div\u003e \u003c/div\u003e \u003cdiv id=\"Sec11\" class=\"Section2\"\u003e \u003ch2\u003e2.7 \u003cem\u003ein vitro\u003c/em\u003e cytotoxicity\u003c/h2\u003e \u003cp\u003eThe compounds were evaluated for their \u003cem\u003ein vitro\u003c/em\u003e cytotoxicity against human cervical cancer cell line (HeLa cells) employing MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) assay as described by Parthasarathy and his colleagues (\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e2020\u003c/span\u003e) with minimal adjustment. A fixed concentration (50 \u0026micro;g/ml) of tested samples was prepared in 100% dimethyl sulphoxide (DMSO) and incubated with HeLa cells in 96-well plate (1 \u0026times; 10\u003csup\u003e4\u003c/sup\u003e cells/mL) cultured and maintained in DMEM with 10% (v/v) fetal bovine serum (FBS) at 37 \u003csup\u003eo\u003c/sup\u003eC for 1 day in an environment of 5% carbon dioxide. Control cells were supplemented with 100 \u0026micro;l with pure DMSO. The number of HeLa cells that survived the tested samples exposure were determined by employing the resazurin-based reagent, and subsequently reading resorufin fluorescence in a multiwell micro-plate reader (VERSAmax, USA) at 595 nm. The experiments were performed in duplicate, and a mean standard deviation (SD) was calculated for each. The results were expressed as percentage (%) cell viability based on the fluorescence reading in treated wells against untreated control wells (Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e).\u003c/p\u003e \u003c/div\u003e"},{"header":"3 Results and discussion","content":"\u003cp\u003eThe present study reports GC-MS analysis and the isolation of bioactive principles of \u003cem\u003eV. paradoxa\u003c/em\u003e, a multipurpose medicinal plant used in African traditional medicine for managing respiratory infections, including tuberculosis and cough. GC-MS profiling of the extract revealed the occurrence of a total of 60 peaks of which 48 chemical compounds were identified. The identified compounds with their peak number, retention time (RT), and peak area (%) are presented in \u003cstrong\u003eTable\u003c/strong\u003e \u003cstrong\u003eS1\u003c/strong\u003e \u003cstrong\u003e(\u003c/strong\u003e\u003cem\u003eSupplementary Information\u003c/em\u003e\u003cstrong\u003e)\u003c/strong\u003e. Out of the 48 detectable chemical constituents in the chromatogram (\u003cem\u003eSupplementary Information\u003c/em\u003e), the major abundant bioactive compounds include hexadecane (11.23%), tetradecane (7.61%), 1-nonadecene (4.81%), 9-octadecenoic acid, methyl ester, (E)- (4.69%), n-pentadecanol (4.43%), 1-heptacosanol (4.15%), hexadecanoic acid, methyl ester (3.58%), glycidyl oleate (3.55%), and 1-hexadecene (3.34%). In addition, the phytochemicals identified in this present study belong to different classes of compounds, and most of them could be employed as antimicrobial agents (\u003cstrong\u003eTable\u003c/strong\u003e \u003cstrong\u003eS1\u003c/strong\u003e and \u003cstrong\u003eFig.\u0026nbsp;2)\u003c/strong\u003e. 1-heptacosanol, a long-chain fatty alcohol, is reported as antimicrobial agent against \u003cem\u003eE. coli\u003c/em\u003e and \u003cem\u003eS. aureus\u003c/em\u003e (Abdi et al., \u003cspan class=\"CitationRef\"\u003e2020\u003c/span\u003e). 2-nonenal, (E)- is a phytoconstituent reported from \u003cem\u003eBrownea grandiceps\u003c/em\u003e (Jacq.) leaves oils with promising antimycobacterial activity against \u003cem\u003eM. tuberculosis\u003c/em\u003e (Korany et al., \u003cspan class=\"CitationRef\"\u003e2021\u003c/span\u003e). Hexadecanoic acid, methyl ester was reported to show promising antimicrobial effect against clinical pathogenic bacteria, including \u003cem\u003eStaphylococcus aureus\u003c/em\u003e, \u003cem\u003ePseudomonas aeruginosa\u003c/em\u003e, \u003cem\u003eKlebsiella pneumoniae\u003c/em\u003e, and \u003cem\u003eK. pneumoniae\u003c/em\u003e (Shaaban et al., \u003cspan class=\"CitationRef\"\u003e2021\u003c/span\u003e). The presence of these compounds could be one of the reasons for the ethnopharmacological uses of the species in the management of respiratory-related infections. In addition, it could also be linked to these identified lipophilic compounds - hexadecane, tetradecane, and 1-nonadecene among others (\u003cstrong\u003eTable\u003c/strong\u003e \u003cstrong\u003eS1\u003c/strong\u003e). These lipophilic compounds possess the ability to weaken the binding mechanism of bacterial cell membranes as well as disrupt the membrane balance, which subsequently lead to cytoplasmic leakage and bacterial cell death (Savoia, \u003cspan class=\"CitationRef\"\u003e2012\u003c/span\u003e).\u003c/p\u003e\n\u003cp\u003eSimilarly, the hexane stem-bark extract was subjected to column chromatography on silica to afford three compounds, including 11-hydroxy \u0026beta;-amyrin cinnamate (\u003cstrong\u003e1\u003c/strong\u003e) (Sirignano et al., \u003cspan class=\"CitationRef\"\u003e2021\u003c/span\u003e), \u0026alpha;-amyrin cinnamate (\u003cstrong\u003e2\u003c/strong\u003e) (Miranda et al., \u003cspan class=\"CitationRef\"\u003e2000\u003c/span\u003e), and sitosterol cinnamate (\u003cstrong\u003e3\u003c/strong\u003e) (Buxton et al., \u003cspan class=\"CitationRef\"\u003e2020\u003c/span\u003e) (\u003cstrong\u003eFig.\u0026nbsp;3\u003c/strong\u003e). The structures of the three compounds were established by analysis of their \u003csup\u003e1\u003c/sup\u003eH, \u003csup\u003e13\u003c/sup\u003eC and 2D-NMR, as well as their mass spectroscopy (Provided in Supplementary List), and by comparison with previously reported data in the literature. Notably, to our knowledge, compounds \u003cstrong\u003e2\u003c/strong\u003e and \u003cstrong\u003e3\u003c/strong\u003e are reported here from the stem-bark of the plant for the first time. In order to explore the contribution of compounds \u003cstrong\u003e1\u003c/strong\u003e\u0026ndash;\u003cstrong\u003e3\u003c/strong\u003e to the ethnobotanical uses of the plant in the treatment of tuberculosis and cough, they were screened against \u003cem\u003eM. smegmatis\u003c/em\u003e (used as model for the pathogenic strain \u003cem\u003eM. tuberculosis\u003c/em\u003e) together with six other bacterial pathogens associated with respiratory tract infections (Table\u0026nbsp;\u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003e) employing 96-well plate microbroth dilution method, and also investigated the cytotoxicity of compounds with the exception of isolate \u003cstrong\u003e3\u003c/strong\u003e which was not assessed to due low amount available.\u003c/p\u003e\n\u003cdiv class=\"gridtable\"\u003e\n\u003ctable id=\"Tab1\" border=\"1\"\u003e\u003ccaption\u003e\n\u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e\n\u003cdiv class=\"CaptionContent\"\u003e\n\u003cp\u003eAntimicrobial and cytotoxicity of tested compounds \u003cstrong\u003e1\u003c/strong\u003e\u0026ndash;\u003cstrong\u003e3\u003c/strong\u003e from \u003cem\u003eVitellaria paradoxa\u003c/em\u003e\u003c/p\u003e\n\u003c/div\u003e\n\u003c/caption\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003e\u0026nbsp;\u003c/th\u003e\n\u003cth colspan=\"7\" align=\"left\"\u003e\n\u003cp\u003eAntimicrobial (MIC, mg/mL)\u003c/p\u003e\n\u003c/th\u003e\n\u003cth align=\"left\"\u003e\n\u003cp\u003eCytotoxicity (IC\u003csub\u003e50\u003c/sub\u003e \u0026micro;g/mL)\u003c/p\u003e\n\u003c/th\u003e\n\u003c/tr\u003e\n\u003c/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cstrong\u003eStrains\u003c/strong\u003e:\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cem\u003eMs\u003c/em\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cem\u003eEc\u003c/em\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cem\u003eKa\u003c/em\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cem\u003eSa\u003c/em\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cem\u003eEcl\u003c/em\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cem\u003eKo\u003c/em\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cem\u003eEf\u003c/em\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eHeLa\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eCompound 1\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e82.53\u0026thinsp;\u0026plusmn;\u0026thinsp;4.06\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eCompound 2\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e1.00\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e1.00\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.50\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e77.82\u0026thinsp;\u0026plusmn;\u0026thinsp;10.5\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eCompound 3\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.125\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.0625\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.250\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.0625\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.0625\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.0625\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.0625\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eNot determined\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cstrong\u003eStreptomycin\u003c/strong\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.004\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.064\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.016\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.256\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.512\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.016\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.128\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\u0026nbsp;\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u003cstrong\u003eNalidixic acid\u003c/strong\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.512\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.512\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.256\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.064\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.016\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e0.008\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003e\u0026gt;\u0026thinsp;0.512\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"left\"\u003e\u0026nbsp;\u003c/td\u003e\n\u003c/tr\u003e\n\u003c/tbody\u003e\n\u003ctfoot\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"9\"\u003e\u003cem\u003eMs - Mycobacterium smegmatis\u003c/em\u003e; \u003cem\u003eEc - Escherischia coli; Ka - Klebsiella aerogenes\u003c/em\u003e; \u003cem\u003eSa\u003c/em\u003e - \u003cem\u003eStaphylococcus aureus\u003c/em\u003e; \u003cem\u003eEcl\u003c/em\u003e - \u003cem\u003eEnterobacter cloacae\u003c/em\u003e; \u003cem\u003eKo\u003c/em\u003e - \u003cem\u003eKlebsiella oxytoca\u003c/em\u003e; \u003cem\u003eEf\u003c/em\u003e - \u003cem\u003eEnterococcus faecalis; HeLa \u0026ndash; Human cancer cell line\u003c/em\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003c/tfoot\u003e\n\u003c/table\u003e\n\u003c/div\u003e\n\u003cp\u003eThe isolated compounds \u003cstrong\u003e1\u003c/strong\u003e\u0026ndash;\u003cstrong\u003e3\u003c/strong\u003e pharmacologically showed the antimycobacterial activity, with sitosterol cinnamate (\u003cstrong\u003e3\u003c/strong\u003e) exhibited the best activity against the inhibition of \u003cem\u003eM. smegmatis\u003c/em\u003e (MIC; 0.125 mg/ml). It also showed the best activity against other tested bacterial strains, with MICs varying from 0.0625 to 0.25 mg/ml (Table\u0026nbsp;\u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003e). When compared with one of the positive controls, compound \u003cstrong\u003e3\u003c/strong\u003e exhibited better or equal activity to the nalidixic acid against \u003cem\u003eM. smegmatis\u003c/em\u003e, \u003cem\u003eE. coli\u003c/em\u003e, \u003cem\u003eK. aerogenes\u003c/em\u003e, \u003cem\u003eS. aureus\u003c/em\u003e, and \u003cem\u003eE. faecalis\u003c/em\u003e. It also displayed better or equal activity against \u003cem\u003eE. coli\u003c/em\u003e, \u003cem\u003eS. aureus\u003c/em\u003e, \u003cem\u003eE. cloacae\u003c/em\u003e, and \u003cem\u003eE. faecalis\u003c/em\u003e in comparison with streptomycin, an antibiotic for treating tuberculosis. Unarguably, structure dictates functions. Structurally, all the isolates \u003cstrong\u003e1\u003c/strong\u003e\u0026ndash;\u003cstrong\u003e3\u003c/strong\u003e (\u003cstrong\u003eFig.\u0026nbsp;3\u003c/strong\u003e) contain cinnamoyl groups at the C-3. It is well-known that cinnamoyl functionality is a component of many drug-like molecules with enhanced biological activities, including antimycobacterial and antimalarial (De et al., \u003cspan class=\"CitationRef\"\u003e2012\u003c/span\u003e; Tanachatchairatana et al., \u003cspan class=\"CitationRef\"\u003e2008\u003c/span\u003e). Presumably, the better activity of compound \u003cstrong\u003e3\u003c/strong\u003e might be connected with structural difference to those of \u003cstrong\u003e1\u003c/strong\u003e and \u003cstrong\u003e2\u003c/strong\u003e, which mainly consist of triterpenoid skeleton. Meanwhile, in setting clinical benchmark, Gibbons (\u003cspan class=\"CitationRef\"\u003e2004\u003c/span\u003e) defined that a plant extract or its natural product has little clinical relevance if its MIC values greater than 1.0 mg/ml. Thus, compounds \u003cstrong\u003e1\u003c/strong\u003e\u0026ndash;\u003cstrong\u003e3\u003c/strong\u003e fall under Gibbons' benchmark, and their inhibitory activities against the tested strains are also reported here for the first time. Also, compounds \u003cstrong\u003e1\u003c/strong\u003e and \u003cstrong\u003e2\u003c/strong\u003e showed a non-toxicity at the single concentration (50.0 \u0026micro;g/ml\u003cstrong\u003e)\u003c/strong\u003e tested against human cancer cell line (HeLa), with compound \u003cstrong\u003e1\u003c/strong\u003e had better toxicity profile with IC\u003csub\u003e50\u003c/sub\u003e of 82.53\u0026thinsp;\u0026plusmn;\u0026thinsp;4.06 \u0026micro;g/ml (Table\u0026nbsp;\u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003e). Plant natural products are considered toxic if the IC\u003csub\u003e50\u003c/sub\u003e value\u0026thinsp;\u0026le;\u0026thinsp;4 \u0026micro;g/ml (Pezzuto, \u003cspan class=\"CitationRef\"\u003e2002\u003c/span\u003e) according to the benchmark by the American National Cancer Institute (NCI). However, it might be erroneous to draw conclusion on the cytotoxicity of the tested compounds. Thus, further studies using normal human cell lines and/or more than one cancer cell lines in \u003cem\u003ein vivo\u003c/em\u003e studies would be valuable to unravel the toxicity of these compounds in rational drug design and development against respiratory infection pathogens, including TB.\u003c/p\u003e"},{"header":"4 Conclusion","content":"\u003cp\u003eThe present study reported identification of 48 phytochemicals using GC-MS, and the chromatographic isolation of three compounds, including 11-hydroxy β-amyrin cinnamate (\u003cb\u003e1\u003c/b\u003e), α-amyrin cinnamate (\u003cb\u003e2\u003c/b\u003e), and sitosterol cinnamate (\u003cb\u003e3\u003c/b\u003e) from \u003cem\u003eVitellaria paradoxa\u003c/em\u003e. The compounds \u003cb\u003e1\u0026ndash;3\u003c/b\u003e showed inhibition of \u003cem\u003eM. smegmatis\u003c/em\u003e, \u003cem\u003eE. coli\u003c/em\u003e, \u003cem\u003eK. aerogenes\u003c/em\u003e, \u003cem\u003eS. aureus\u003c/em\u003e, \u003cem\u003eE. cloacae\u003c/em\u003e, \u003cem\u003eK. oxytoca\u003c/em\u003e, and \u003cem\u003eE. faecalis\u003c/em\u003e, and their antimicrobial activities are reported here for the first time to our knowledge. Likewise, compounds \u003cb\u003e2\u003c/b\u003e and \u003cb\u003e3\u003c/b\u003e are isolated from the stem-bark of the plant for the first time in this study. Antibacterial activities of these compounds could provide some scientific justifications for the ethnomedicinal uses of \u003cem\u003eV. paradoxa\u003c/em\u003e in the treatment of respiratory disorders, including tuberculosis.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eConflicts of Interest\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that they have no conflict of interest.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis work was supported financially by the South African TWAS-NRF Fellowships (Ref: Grant Numbers 116110 \u0026amp; 139057).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors are grateful to the National Research Foundation, South Africa, as well as The World Academy of Sciences, Italy for providing research fund for this work.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCRediT authorship contribution statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eOlusesan Ojo:\u003c/strong\u003e Conceptualization, Methodology, Data curation, Data analysis, Writing - original draft, Funding acquisition. \u003cstrong\u003eEdwin M. Mmutlane:\u003c/strong\u003e Writing - review \u0026amp; editing, Supervision. \u003cstrong\u003eDerek T. Ndinteh:\u003c/strong\u003e Conceptualization, Supervision, Writing - review \u0026amp; editing, Funding acquisition\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eAbdi, B., Getaneh, E., Gelaw, T., Dekebo, A., Tesso, H., Abdo, T., Melaku, Y., 2020. Chemical constituents of the roots extract of \u003cem\u003eDryopteris schimperiana\u003c/em\u003e and evaluation for antibacterial and radical scavenging activities. Ethiopian Journal of Science and Sustainable Development 7, 2020. https://doi.org/10.20372/ejssdastu:v7.i1.2020.153\u003c/li\u003e\n\u003cli\u003eAkihisa, T., Kojima, N., Kikuchi, T., Yasukawa, K., Tokuda, H., T. Masters, E., Manosroi, A., Manosroi, J., 2010. Anti-inflammatory and chemopreventive effects of triterpene cinnamates and acetates from Shea Fat. Journal of Oleo Science 59, 273\u0026ndash;280. https://doi.org/10.5650/jos.59.273\u003c/li\u003e\n\u003cli\u003eAriyo, O.C., Usman, M.B., Olorukooba, M.M., Ariyo, M.O., Suleiman, R., Aasa, O.S., Adetunji, A.J., Oni, O.B., 2020. Ethnobotanical survey of medicinal plants used in the treatment of cough in Akinyele Local Government Area, Oyo State, Nigeria. European Journal of Medicinal Plants 101\u0026ndash;113. https://doi.org/10.9734/ejmp/2020/v31i830263\u003c/li\u003e\n\u003cli\u003eAtanasov, A.G., Zotchev, S.B., Dirsch, V.M., Supuran, C.T., 2021. Natural products in drug discovery: advances and opportunities. Nature Reviews Drug and Discovery 20, 200\u0026ndash;216. https://doi.org/10.1038/s41573-020-00114-z\u003c/li\u003e\n\u003cli\u003eBuxton, T., Takahashi, S., Eddy Doh, A.-M., Baffoe-Ansah, J., Owusu, E.O., Kim, C.-S., 2020. Insecticidal activities of cinnamic acid esters isolated from \u003cem\u003eOcimum gratissimum\u003c/em\u003e L. and \u003cem\u003eVitellaria paradoxa\u003c/em\u003e Gaertn leaves against \u003cem\u003eTribolium castaneum\u003c/em\u003e Hebst (Coleoptera: Tenebrionidae). Pest Management Science 76, 257\u0026ndash;267. https://doi.org/10.1002/ps.5509\u003c/li\u003e\n\u003cli\u003eda Costa, A.V., Cal\u0026aacute;bria, L.K., Furtado, F.B., de Gouveia, N.M., Oliveira, R.J. da S., de Oliveira, V.N., Beletti, M.E., Espindola, F.S., 2013. Neuroprotective effects of \u003cem\u003ePouteria ramiflora\u003c/em\u003e (Mart.) Radlk (Sapotaceae) extract on the brains of rats with streptozotocin-induced diabetes. Metabolic Brain Disease 28, 411\u0026ndash;419. https://doi.org/10.1007/s11011-013-9390-6\u003c/li\u003e\n\u003cli\u003eDe, P., Bedos-Belval, F., Vanucci-Bacqu\u0026eacute;, C., Baltas, M., 2012. Cinnamic acid derivatives in tuberculosis, malaria and cardiovascular diseases - A review. Current Organic Chemistry 16, 747\u0026ndash;768. https://doi.org/10.2174/138527212799958020\u003c/li\u003e\n\u003cli\u003eDemissie, B.W., Amele, E.A., Yitayew, Y.A., Yalew, Z.M., 2021. Acute lower respiratory tract infections and associated factors among under-five children visiting Wolaita Sodo University Teaching and Referral Hospital, Wolaita Sodo, Ethiopia. BMC Pediatrics 21, 413. https://doi.org/10.1186/s12887-021-02888-6\u003c/li\u003e\n\u003cli\u003eDong, M., Pfeiffer, B., Altmann, K.-H., 2017. Recent developments in natural product-based drug discovery for tuberculosis. Drug Discovery Today 22, 585\u0026ndash;591. https://doi.org/10.1016/j.drudis.2016.11.015\u003c/li\u003e\n\u003cli\u003eEloff, J., 1999. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Medica 64, 711\u0026ndash;3. https://doi.org/10.1055/s-2006-957563\u003c/li\u003e\n\u003cli\u003eForum of International Respiratory Societies. European Respiratory Society, 2017. The global impact of respiratory disease - Second edition. Sheffield. pp. 56 -89\u003c/li\u003e\n\u003cli\u003eGibbons, S., 2004. Anti-staphylococcal plant natural products. Natural Product Reports 21, 263\u0026ndash;77. https://doi.org/10.1039/b212695h\u003c/li\u003e\n\u003cli\u003eGlobal tuberculosis report 2020. URL https://www.who.int/publications-detail-redirect/9789240013131 (accessed 9.7.21).\u003c/li\u003e\n\u003cli\u003eHusain, M., Valayer, S., Poey, N., Rondinaud, E., d\u0026rsquo;Humi\u0026egrave;res, C., Visseaux, B., Lariven, S., Lescure, F., Deconinck, L., 2021. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards. Infectious Diseases Now, 1-22. https://doi.org/10.1016/j.idnow.2021.12.001\u003c/li\u003e\n\u003cli\u003eIkuta, A., Morikawa, A., 1992. Triterpenes from \u003cem\u003eStauntonia hexaphylla\u003c/em\u003e callus tissues. Journal of Natural Products 55, 1230\u0026ndash;1233. https://doi.org/10.1021/np50087a008\u003c/li\u003e\n\u003cli\u003eKorany, D.A., Ayoub, I.M., Labib, R.M., El-Ahmady, S.H., Singab, A.N.B., 2021. The impact of seasonal variation on the volatile profile of leaves and stems of \u003cem\u003eBrownea grandiceps\u003c/em\u003e (Jacq.) with evaluation of their anti-mycobacterial and anti-inflammatory activities. South African Journal of Botany 142, 88\u0026ndash;95. https://doi.org/10.1016/j.sajb.2021.06.013\u003c/li\u003e\n\u003cli\u003eKuete, V., BetrandTeponno, R., Mbaveng, A.T., Tapondjou, L.A., Meyer, J.J.M., Barboni, L., Lall, N., 2012. Antibacterial activities of the extracts, fractions and compounds from \u003cem\u003eDioscorea bulbifera\u003c/em\u003e. BMC Complementary and Alternative Medicine 12, 228. https://doi.org/10.1186/1472-6882-12-228\u003c/li\u003e\n\u003cli\u003eKumatia, E.K., Appiah-Opong, R., 2021. The hydroethanolic stem bark extract of \u003cem\u003eTieghemella heckelii\u003c/em\u003e (A.Chev.) Pierre ex Dubard (Sapotaceae) produced N-methyl-D-aspartate (NMDA) receptor-dependent analgesia and attenuates acute inflammatory pain via disruption of oxidative stress. Evidence-Based Complementary and Alternative Medicine 2021, e3466757. https://doi.org/10.1155/2021/3466757\u003c/li\u003e\n\u003cli\u003eLawal, I.O., Olufade, I.I., Rafiu, B.O., Aremu, A.O., 2020. Ethnobotanical survey of plants used for treating cough associated with respiratory conditions in Ede South Local Government Area of Osun State, Nigeria. Plants (Basel) 9, E647. https://doi.org/10.3390/plants9050647\u003c/li\u003e\n\u003cli\u003eLee, S.H., Ruan, S.-Y., Pan, S.-C., Lee, T.-F., Chien, J.-Y., Hsueh, P.-R., 2019. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units. Journal of Microbiology, Immunology and Infection 52, 920\u0026ndash;928. https://doi.org/10.1016/j.jmii.2019.10.009\u003c/li\u003e\n\u003cli\u003eMcGaw, L.J., Awouafack, M.D., Sakong, B.M., Makhafola, T.J., Hlokwe, T.M., Madoroba, E., Eloff, J.N., 2015. The sapotaceae as a source of antitubercular metabolites and isolation of antimycobacterial pentacyclic triterpenes from \u003cem\u003eSideroxylon inerme\u003c/em\u003e. Planta Medica 81, PW_23. https://doi.org/10.1055/s-0035-1565647\u003c/li\u003e\n\u003cli\u003eMichaud, C.M., 2009. Global burden of infectious diseases. Encyclopedia of Microbiology 444\u0026ndash;454. https://doi.org/10.1016/B978-012373944-5.00185-1\u003c/li\u003e\n\u003cli\u003eMiranda, A.L.P. de, Silva, J.R.A., Rezende, C.M., Neves, J.S., Parrini, S.C., Pinheiro, M.L.B., Cordeiro, M.C., Tamborini, E., Pinto, A.C., 2000. Anti-Inflammatory and analgesic activities of the latex containing triterpenes from \u003cem\u003eHimatanthus sucuuba\u003c/em\u003e. Planta Medica 66, 284\u0026ndash;286. https://doi.org/10.1055/s-2000-8572\u003c/li\u003e\n\u003cli\u003eMirzayev, F., Viney, K., Linh, N.N., Gonzalez-Angulo, L., Gegia, M., Jaramillo, E., Zignol, M., Kasaeva, T., 2021. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. European Respiratory Journal 57, 1-16 https://doi.org/10.1183/13993003.03300-2020\u003c/li\u003e\n\u003cli\u003eNadembega, P., Boussim, J.I., Nikiema, J.B., Poli, F., Antognoni, F., 2011. Medicinal plants in Baskoure, Kourittenga Province, Burkina Faso: An ethnobotanical study. Journal of Ethnopharmacology 133, 378\u0026ndash;395. https://doi.org/10.1016/j.jep.2010.10.010\u003c/li\u003e\n\u003cli\u003eOgbole, O.O., Ajaiyeoba, E.O., 2009. Traditional management of tuberculosis in Ogun State of Nigeria: the practice and ethnobotanical survey. Africa Journal of Traditional, Complementary and Alternative Medicine 7, 79\u0026ndash;84. https://doi.org/10.4314/ajtcam.v7i1.57270\u003c/li\u003e\n\u003cli\u003eOjo, O., Kengne, M.H.K., Fotsing, M.C., Mmutlane, E.M., Ndinteh, D.T., 2021. Traditional uses, phytochemistry, pharmacology and other potential applications of \u003cem\u003eVitellaria paradoxa\u003c/em\u003e Gaertn. (Sapotaceae): A review. Arabian Journal of Chemistry 14, 103213. https://doi.org/10.1016/j.arabjc.2021.103213\u003c/li\u003e\n\u003cli\u003eParthasarathy, R., Shanmuganathan, R., Pugazhendhi, A., 2020. Vinblastine production by the endophytic fungus \u003cem\u003eCurvularia verruculosa\u003c/em\u003e from the leaves of \u003cem\u003eCatharanthus roseus\u003c/em\u003e and its \u003cem\u003ein vitro\u003c/em\u003e cytotoxicity against HeLa cell line. Analytical Biochemistry 593, 113530. https://doi.org/10.1016/j.ab.2019.113530\u003c/li\u003e\n\u003cli\u003ePassarelli-Araujo, H., Palmeiro, J.K., Moharana, K.C., Pedrosa-Silva, F., Dalla-Costa, L.M., Venancio, T.M., 2019. Genomic analysis unveils important aspects of population structure, virulence, and antimicrobial resistance in \u003cem\u003eKlebsiella aerogenes\u003c/em\u003e. The FEBS Journal 286, 3797\u0026ndash;3810. https://doi.org/10.1111/febs.15005\u003c/li\u003e\n\u003cli\u003ePezzuto, J.M., 2002. Natural Compounds in Cancer Therapy. Pharmaceutical Biology 40, 79\u0026ndash;79. https://doi.org/10.1076/phbi.40.1.79.5858\u003c/li\u003e\n\u003cli\u003ePorras, G., Chassagne, F., Lyles, J.T., Marquez, L., Dettweiler, M., Salam, A.M., Samarakoon, T., Shabih, S., Farrokhi, D.R., Quave, C.L., 2021. Ethnobotany and the role of plant natural products in antibiotic drug discovery. Chemical Reviews 121, 3495\u0026ndash;3560. https://doi.org/10.1021/acs.chemrev.0c00922\u003c/li\u003e\n\u003cli\u003ePrat, C., Lacoma, A., 2016. Bacteria in the respiratory tract\u0026mdash;how to treat? Or do not treat? International Journal of Infectious Diseases 51, 113\u0026ndash;122. https://doi.org/10.1016/j.ijid.2016.09.005\u003c/li\u003e\n\u003cli\u003eSavoia, D., 2012. Plant-derived antimicrobial compounds: alternatives to antibiotics. Future Microbiology 7, 979\u0026ndash;990. https://doi.org/10.2217/fmb.12.68\u003c/li\u003e\n\u003cli\u003eShaaban, M.T., Ghaly, M.F., Fahmi, S.M., 2021. Antibacterial activities of hexadecanoic acid methyl ester and green-synthesized silver nanoparticles against multidrug-resistant bacteria. Journal of Basic Microbiology 61, 557\u0026ndash;568. https://doi.org/10.1002/jobm.202100061\u003c/li\u003e\n\u003cli\u003eSirignano, C., Nadembega, P., Poli, F., Romano, B., Lucariello, G., Rigano, D., Taglialatela-Scafati, O., 2021. Triterpenoids from \u003cem\u003eVitellaria paradoxa\u003c/em\u003e stem barks reduce nitrite levels in LPS-stimulated macrophages. Plants 10, 1006. https://doi.org/10.3390/plants10051006\u003c/li\u003e\n\u003cli\u003eTanachatchairatana, T., Bremner, J.B., Chokchaisiri, R., Suksamrarn, A., 2008. Antimycobacterial activity of cinnamate-based esters of the triterpenes betulinic, oleanolic and ursolic acids. Chemical and Pharmaceutical Bulletin 56, 194\u0026ndash;198. https://doi.org/10.1248/cpb.56.194\u003c/li\u003e\n\u003cli\u003eYoo, I.Y., Huh, K., Shim, H.J., Yun, S.A., Chung, Y.N., Kang, O.K., Huh, H.J., Lee, N.Y., 2020. Evaluation of the BioFire FilmArray Pneumonia Panel for rapid detection of respiratory bacterial pathogens and antibiotic resistance genes in sputum and endotracheal aspirate specimens. International Journal of Infectious Diseases 95, 326\u0026ndash;331. https://doi.org/10.1016/j.ijid.2020.03.024\u003c/li\u003e\n\u003cli\u003eZhong, Q., Feng, H., Lu, Q., Liu, X., Zhao, Q., Du, Y., Zhang, X.-H., Wang, J.-R., 2018. Recurrent wheezing in neonatal pneumonia is associated with combined infection with respiratory syncytial virus and \u003cem\u003eStaphylococcus aureus\u003c/em\u003e or \u003cem\u003eKlebsiella pneumoniae\u003c/em\u003e. Scientific Reports 8, 995. https://doi.org/10.1038/s41598-018-19386-y\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[{"identity":"b0898c72-fb8c-492c-97c3-a81ef3430638","identifier":"10.13039/501100001321","name":"National Research Foundation","awardNumber":"139057","order_by":0}],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"National Research Foundation, South Africa","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Vitellaria paradoxa, Sapotaceae, Respiratory tract infections, Tuberculosis, Cytotoxicity, Sitosterol cinnamate","lastPublishedDoi":"10.21203/rs.3.rs-3967817/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3967817/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e \u003cem\u003eVitellaria paradoxa\u003c/em\u003e Gaertn. is a commonly used medicinal plant for the treatment of tuberculosis (TB) and other respiratory infections in Africa. Therefore, its phytochemicals can be explored in rational drug discovery, development, and design against respiratory-tract infections. The aim of this study is to identify chemical composition of \u003cem\u003eV. paradoxa\u003c/em\u003e hexane stem-bark extract, and further isolate possible antimicrobial agents from its crude extract. 48 phytochemicals, including1-heptacosanol, 2-nonenal, (E)-, and hexadecanoic acid, methyl ester were identified using GC-MS. Column chromatography led to the isolation of three compounds, including 11-hydroxy β-amyrin cinnamate (\u003cb\u003e1\u003c/b\u003e), α-amyrin cinnamate (\u003cb\u003e2\u003c/b\u003e), and sitosterol cinnamate (\u003cb\u003e3\u003c/b\u003e). All the compounds showed activity against all the tested pathogens, with compound (\u003cb\u003e3\u003c/b\u003e) showed better activity against all bacterial strains, with minimum inhibitory concentrations (MICs) varying from 0.0625 to 0.25 mg/ml. Compounds (\u003cb\u003e1\u003c/b\u003e) and (\u003cb\u003e2\u003c/b\u003e) showed no cytotoxicity against the cervical cancer cell line (HeLa) (IC\u003csub\u003e50\u003c/sub\u003e; 82.53\u0026thinsp;\u0026plusmn;\u0026thinsp;4.07 and 77.82\u0026thinsp;\u0026plusmn;\u0026thinsp;10.5 respectively). To our knowledge, compounds \u003cb\u003e2\u003c/b\u003e and \u003cb\u003e3\u003c/b\u003e are reported here from the stem-bark part of the plant for the first time. Similarly, inhibitory activities of compounds \u003cb\u003e1\u003c/b\u003e\u0026ndash;\u003cb\u003e3\u003c/b\u003e against the tested strains are studied here for the first time. These results provide in part scientific justification for the traditional uses of \u003cem\u003eV. paradoxa\u003c/em\u003e for treating respiratory tract infections, including tuberculosis in Africa.\u003c/p\u003e","manuscriptTitle":"Inhibitory Activity of Chemical Constituents from Vitellaria paradoxa Gaertn. (Sapotaceae) Against Pathogens Associated with Respiratory Tract Infections","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-02-20 15:17:08","doi":"10.21203/rs.3.rs-3967817/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"59396224-0ef8-4fd5-b6c9-c9c107e36f21","owner":[],"postedDate":"February 20th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":28826272,"name":"Medicinal Chemistry"}],"tags":[],"updatedAt":"2024-02-20T15:17:08+00:00","versionOfRecord":[],"versionCreatedAt":"2024-02-20 15:17:08","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-3967817","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3967817","identity":"rs-3967817","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}